<SEC-DOCUMENT>0001628280-20-017414.txt : 20201211
<SEC-HEADER>0001628280-20-017414.hdr.sgml : 20201211
<ACCEPTANCE-DATETIME>20201211170157
ACCESSION NUMBER:		0001628280-20-017414
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		4
FILED AS OF DATE:		20201211
DATE AS OF CHANGE:		20201211

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUMBERLAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001087294
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-251308
		FILM NUMBER:		201384260

	BUSINESS ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE,
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		615-255-0068

	MAIL ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>a2020decs-3document.htm
<DESCRIPTION>S-3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="ib5b5c1fb12bd44019bcb194945c93970_55"></div><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As filed with the Securities and Exchange Commission on December 11, 2020</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registration No. 333-&#91;&#9679;&#93;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">Form S-3 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">REGISTRATION STATEMENT</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">UNDER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">THE SECURITIES ACT OF 1933</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%">CUMBERLAND PHARMACEUTICALS INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:85.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tennessee<br>(State or other jurisdiction of<br>incorporation or organization)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">62-1765329</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IRS Employer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Identification No.)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Michael Bonner</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Chief Financial Officer</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2525 West End Avenue, Suite 950<br>Nashville, Tennessee 37203<br>(615) 255-0068</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cumberland Pharmaceuticals Inc.<br>2525 West End Avenue, Suite 950<br>Nashville, Tennessee 37203<br>(615) 255-0068</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Address, including zip code, and telephone number,<br>including area code, of registrant&#8217;s principal executive offices)</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Name and address, including zip code, and telephone<br>number, including area code, of agent for service)</font></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">With copies to&#58;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tonya Mitchem Grindon, Esq.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Christopher M. Douse, Esq.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Baker, Donelson, Bearman, Caldwell &#38; Berkowitz, PC</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Baker Donelson Center</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Suite 800</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">211 Commerce Street</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nashville, Tennessee 37201</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">615-726-5600</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximate date of commencement of proposed sale of securities to the public&#58; From time to time after the effective date of this registration statement.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. &#9744;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box. &#9746;</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If this Form is a post-effective amendment filed pursuant to Rule 462 (c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. &#9744;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. &#9744;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and emerging growth company in Rule 12b-2 of the Exchange Act.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Large accelerated filer&#160;&#160;&#160;&#160;&#9744;&#160;&#160;&#160;&#160;Accelerated filer&#160;&#160;&#160;&#160;&#9744;</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-accelerated filer&#160;&#160;&#160;&#160;&#9746;  &#160;&#160;&#160;&#160;Smaller reporting company&#160;&#160;&#160;&#160;&#9746;</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;&#160;&#160;&#160;&#9744;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of Securities Act. &#9744;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.111%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CALCULATION OF REGISTRATION FEE</font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:84.861%"><tr><td style="width:1.0%"></td><td style="width:67.312%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.230%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.158%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Title of each class of<br>securities to be registered(1)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount to be registered &#47;proposed maximum offering price per unit&#47; proposed maximum offering price(2)</font></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount of registration fee(3)</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common Stock</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preferred Stock</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warrants</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt Securities</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Units</font></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</font></td><td colspan="3" style="border-bottom:3pt double #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$100,000,000</font></td><td colspan="3" style="border-bottom:3pt double #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$10,910.00</font></td></tr></table></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) Any securities registered hereunder may be sold separately or as units with other securities registered hereunder. The securities which may be offered pursuant to this Registration Statement include, pursuant to Rule 416 of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), such additional number of shares of the registrant&#8217;s common stock that may become issuable as a result of any split, stock dividends or similar event. &#160;&#160;&#160;&#160;</font></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) An indeterminate aggregate offering price and number or amount of the securities of each identified class is being registered as may from time to time be sold at indeterminate prices, with a maximum aggregate offering price not to exceed $100,000,000. Separate consideration may or may not be received for securities that are issuable upon conversion of, or in exchange for, or upon exercise of, convertible or exchangeable securities.  </font></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3) Pursuant to Rule 457(o) under the Securities Act, the registration fee has been calculated on the basis of the maximum aggregate offering price. Pursuant to Rule 457(p) under the Securities Act, the registrant is offsetting the registration fee due under this registration statement by $10,910.00 with $1,514.98 remaining to be applied to future filings, which represents the portion of the registration fee previously paid with respect to $99,799,091.00 of unsold securities previously registered on the registration statement on Form S-3 (File No. 333-221402), initially filed on November 7, 2017 and declared effective on January 16, 2018. </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________</font></div><div><font><br></font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until this registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The information in this prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subject to completion, dated December 11, 2020</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROSPECTUS</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%">$100,000,000</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%">CUMBERLAND PHARMACEUTICALS INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Common Stock</font></div><div style="margin-bottom:0.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Preferred Stock</font></div><div style="margin-bottom:0.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Warrants</font></div><div style="margin-bottom:0.1pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Debt Securities</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Units</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________</font></div><div><font><br></font></div><div style="margin-bottom:10pt;text-align:center"><font><br></font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may offer and sell, from time to time in one or more offerings, up to $100,000,000 in the aggregate of common stock, preferred stock, or warrants to purchase our common stock or preferred stock, debt securities and&#47;or units consisting of two or more of those classes or series of securities and securities that may be convertible or exchangeable to other securities covered hereby,  at prices and on terms that we will determine at the time of the offering. Preferred stock and debt securities may be convertible into preferred stock, common stock, or debt securities. We refer to our common stock, preferred stock, debt securities, warrants, and units hereunder collectively as the &#8220;securities.&#8221; </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each time we sell securities, to the extent required by applicable law, we will provide a supplement to this prospectus that contains specific information about the offering and the terms of the securities being offered. The supplement may also add, update or change information contained in this prospectus. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">You should carefully read this prospectus, all prospectus supplements and all other documents incorporated by reference in this prospectus before you invest in our securities.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will offer the securities in amounts, at prices and on terms to be determined by market conditions at the time of the offerings. The securities may be offered separately or together in any combination.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may offer the securities directly or through underwriters, agents or dealers. The supplements to this prospectus will designate the terms of our plan of distribution. See the discussion under the heading &#8220;Plan of Distribution&#8221; for more information on the topic.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our executive offices are located at 2525 West End Avenue, Suite 950, Nashville, Tennessee 37203, and our telephone number is (615) 255-0068.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock trades on the Nasdaq Global Select Market under the symbol &#8220;CPIX.&#8221; On December 10, 2020, the closing price for our common stock, as reported by Nasdaq, was $3.01 per share.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________</font></div><div><font><br></font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investing in our securities involves risk. Please see &#8220;Risk Factors&#8221; beginning on page 2 for a discussion of certain risks that you should consider before investing in our securities.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</font></div><div style="margin-bottom:10pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus may not be used to consummate sales of securities unless accompanied by a prospectus supplement.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The date of this prospectus is &#160;&#160;&#160;&#160;, 2020. </font></div><div style="text-align:center"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:85.000%"><tr><td style="width:1.0%"></td><td style="width:93.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.129%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ABOUT THIS PROSPECTUS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RISK FACTORS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CAUTIONARY STATEMENTS REGARDING FORWARD-LOOKING STATEMENTS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OUR COMPANY</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">USE OF PROCEEDS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DESCRIPTION OF CAPITAL STOCK</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DESCRIPTION OF WARRANTS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DESCRIPTION OF DEBT SECURITIES</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DESCRIPTION OF UNITS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PLAN OF DISTRIBUTION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LEGAL MATTERS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EXPERTS</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHERE YOU CAN FIND MORE INFORMATION</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INFORMATION INCORPORATED BY REFERENCE</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</font></div></td></tr></table></div><div id="ib5b5c1fb12bd44019bcb194945c93970_1"></div><div style="-sec-extract:summary"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ABOUT THIS PROSPECTUS</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This prospectus is part of a registration statement that we have filed with the Securities and Exchange Commission using a &#8220;shelf&#8221; registration process. Using this process, we may sell any combination of the securities described in this prospectus in one or more offerings up to a total dollar amount of $100,000,000.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each time we use this prospectus to offer securities, we will provide a prospectus supplement that will describe the specific terms of the offering.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The prospectus supplement may also add to or update other information contained in this prospectus.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In making your investment decision, you should rely only on the information contained or incorporated by reference in this prospectus and any prospectus supplement we may authorize to be delivered to you. This prospectus incorporates important business and financial information about us that is not included in or delivered with this prospectus. You may obtain a copy of this information, without charge, as described in the &#8220;Where You Can Find More Information&#8221; section. We have not authorized anyone to provide you with any other information. If you receive any other information, you should not rely on it.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should not assume that the information appearing in this prospectus is accurate as of any date other than the date on the front cover of this prospectus. You should not assume that the information contained in the documents incorporated by reference in this prospectus is accurate as of any date other than the respective dates of those documents. Our business, financial condition, results of operations, reserves and prospects may have changed since that date.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We encourage you to read this entire prospectus together with the documents incorporated by reference into this prospectus before making a decision whether to invest in our securities.</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISK FACTORS</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An investment in our securities involves a certain degree of risk. You should carefully consider the factors contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019 under the heading &#8220;Risk Factors&#8221; and updated, if applicable, in our Quarterly Reports on Form 10-Q before investing in our securities. You should also consider similar information contained in any Annual Report on Form 10-K, Quarterly Report on Form 10-Q or other document filed by us with the SEC after the date of this prospectus before deciding to invest in our securities. If any of these risks were to occur, our business, financial condition or results of operations could be adversely affected. In that case, the trading price of our common stock or other securities could decline and you could lose all or part of your investment. When we offer and sell any securities pursuant to a prospectus supplement, we may include additional risk factors relevant to such securities in the prospectus supplement.</font></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY STATEMENTS REGARDING FORWARD-LOOKING STATEMENTS</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information included in this prospectus may be deemed to be forward-looking statements. Where any forward-looking statement includes a statement of the assumptions or bases underlying the forward-looking statement, we caution that, while we believe these assumptions or bases to be reasonable and made in good faith, assumed facts or bases almost always vary from the actual results, and the differences between assumed facts or bases and actual results can be material, depending upon the circumstances. Where, in any forward-looking statement, we express an expectation or belief as to future results, such expectation or belief is expressed in good faith and is believed to have a reasonable basis. We cannot assure you, however, that the statement of expectation or belief will result or be achieved or accomplished. These statements relate to analyses and other information which are based on forecasts of future results and estimates of amounts not yet determinable. These statements also relate to our future prospects, developments and business strategies. These forward-looking statements are identified by their use of terms and phrases such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;will,&#8221; and similar terms and phrases, or the  negative of these words and phrases or similar words or phrases, which are predictions of or indicate future events or trends and which do not relate solely to historical matters.  You can also identify forward-looking statements by discussions of strategy, plans or intentions.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements involve numerous risks and uncertainties and you should not rely on them as predictions of future events.  Forward-looking statements depend on assumptions, data or methods which may be incorrect or imprecise and we may not be able to realize them.  We do not guarantee that the transactions and events described will happen as described (or that they will happen at all).  The following factors, among others, could cause actual results and future events to differ materially from those set forth or contemplated in the forward-looking statements&#58;</font></div><div style="padding-left:63pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.46pt">The possible or assumed future results of operations, including the accuracy of our estimates regarding expenses, future revenues, capital requirements and needs for additional financing&#59; </font></div><div style="padding-left:63pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.46pt">Changes in national or regional economic conditions, including changes in interest rates and the availability and the cost of capital to us&#59;</font></div><div style="padding-left:63pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.46pt">Our competitive position and competitors, including the size and growth potential of the markets for our products and product candidates&#59;</font></div><div style="padding-left:63pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.46pt">The success, cost and timing of our product acquisition and development activities and clinical trials&#59; and our ability to successfully commercialize our product candidates&#59;</font></div><div style="padding-left:63pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.46pt">Product efficacy or safety concerns, whether or not based on scientific evidence, resulting in product withdrawals, recalls, regulatory action on the part of the FDA (or international counterparts) or declining sales&#59;</font></div><div style="padding-left:63pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.46pt">The performance of our third-party suppliers and manufacturers which impacts our supply chain and could create business shutdowns or product shortages&#59; and the retention of key scientific and management personnel&#59;</font></div><div style="padding-left:63pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.46pt">Challenges to our patents and the introduction of generic versions of our products and product candidates, which could negatively impact our ability to commercialize and sell our products and product candidates and decrease sales a result of a market exclusivity&#59;</font></div><div style="padding-left:63pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.46pt">Changes in reimbursement available to us, including changes in Medicare and Medicaid payment levels and availability of third-party insurance coverage and the effects of future legislation or regulations, including changes to regulatory approval of new products, licensing and patent rights, environmental protection and possible drug re-importation legislation&#59;</font></div><div style="padding-left:63pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.46pt">Interruptions and breaches of our computer and communications systems, and those of our vendors, including computer viruses, hacking and cyber-attacks, that could impair our ability to conduct business and communicate internally and with our customers, or result in the theft of trade secrets or other misappropriation of assets, or otherwise compromise privacy of sensitive information belonging to us, our customers or other business partners&#59; and </font></div><div style="padding-left:63pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.46pt">Issuance of new or revised accounting standards by the Financial Accounting Standards Board and the Securities and Exchange Commission (the &#8220;SEC&#8221;).</font></div><div style="padding-left:27pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information or otherwise. If one or more of these risks or uncertainties materialize, or if underlying assumptions prove incorrect, our actual results may vary materially from those expected, estimated or projected.</font></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OUR COMPANY</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In this prospectus, &#8220;Cumberland,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; and &#8220;us&#8221; refer to Cumberland Pharmaceuticals Inc.</font></div><div style="text-align:justify;text-indent:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland is a Tennessee corporation. Our principal executive offices are located at 2525 West End Avenue, Suite 950, Nashville, Tennessee 37203. Our telephone number is (615) 255-0068. We maintain a website at </font><font style="background-color:#ffffff;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">www.cumberlandpharma.com</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which contains information about us. Our website and the information contained on it and connected to it will not be deemed incorporated by reference into this prospectus.  We were incorporated in 1999 and have been headquartered in Nashville, Tennessee since inception.  During 2009, we completed an initial public offering of our common stock, which is listed on Nasdaq under the symbol &#8220;CPIX.&#8221;. </font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. Our primary target markets are hospital acute care and gastroenterology. These medical specialties are characterized by relatively concentrated prescriber bases that we believe can be penetrated effectively by small, targeted sales forces. Cumberland is dedicated to providing innovative products that improve quality of care for patients and address unmet or poorly met medical needs. We promote our approved products through our hospital and field sales forces in the United States and are establishing a network of international partners to bring our products to patients in their countries.</font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our portfolio of FDA approved brands includes&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acetadote&#174; (acetylcysteine) Injection, for the treatment of acetaminophen poisoning&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Caldolor&#174; (ibuprofen) Injection for the treatment of pain and fever&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kristalose&#174; (lactulose) for Oral Solution, a prescription laxative, for the treatment of chronic and acute constipation&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Omeclamox&#174;-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori (H. pylori) infection and related duodenal ulcer disease&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vaprisol&#174; (conivaptan) Injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vibativ&#174; (telavancin) Injection, for the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RediTrex</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (methotrexate) Injection, for the treatment of active rheumatoid, juvenile idiopathic and severe psoriatic arthritis, as well as disabling psoriasis.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we have Phase II clinical programs underway evaluating our ifetroban product candidates in patients with cardiomyopathy associated with Duchenne Muscular Dystrophy (&#8220;DMD&#8221;), Systemic Sclerosis (&#8220;SSc&#8221;), and Aspirin-Exacerbated Respiratory Disease (&#34;AERD&#34;). We have also completed Phase II clinical programs with ifetroban in patients with Hepatorenal Syndrome (&#8220;HRS&#8221;) and patients with Portal Hypertension (&#8220;PH&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has both product development and commercial capabilities and we believe we can leverage our existing infrastructure to support our expected growth. Our management team consists of pharmaceutical industry veterans experienced in business development, product development, regulatory, manufacturing, sales, marketing and finance. Our business development team identifies, evaluates and negotiates product acquisition, licensing and co-promotion agreements. Our product development team creates proprietary product formulations, manages our clinical studies, prepares all regulatory submissions and staffs our medical call center. Our quality and manufacturing professionals oversee the manufacture, release and shipment of our products. Our marketing and sales team is responsible for our commercial activities, and we work closely with our distribution partners to ensure availability and delivery of our products.</font></div><div style="text-align:justify;text-indent:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland's growth strategy involves maximizing the potential of our existing brands, while continuing to build a portfolio of differentiated products. We currently feature seven FDA approved products for sale in the United States. Through our international partners, we are working to bring our medicines to patients in their countries. We also look for opportunities to expand our products into additional patient populations through clinical trials, through new presentations, and through our support for select, investigator-initiated studies. We also actively pursue opportunities to acquire additional marketed products, as well as late-stage development product candidates in our target medical specialties. Our clinical team is developing a pipeline of new product candidates largely to address unmet medical needs.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="text-align:justify;text-indent:18pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, we are supplementing these activities with the earlier stage drug development at Cumberland Emerging Technologies (&#34;CET&#34;), our majority-owned subsidiary. CET partners with academic research institutions to identify and progress promising, new product candidates, which Cumberland has the opportunity to further develop and commercialize.</font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font><br></font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">USE OF PROCEEDS</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise specified in a prospectus supplement accompanying this prospectus, we expect to use the net proceeds from the sale of our securities for general corporate purposes, which may include, among other things, the financing of capital expenditures, acquisitions and additions to our working capital. The actual application of proceeds from the sale of any particular tranche of securities issued hereunder will be described in the applicable prospectus supplement relating to such tranche of securities.</font></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DESCRIPTION OF CAPITAL STOCK</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our authorized capital consists of 120,000,000 shares of stock at no par value. Of the authorized capital, 100,000,000 shares are authorized to be issued as common stock and 20,000,000 shares are authorized to be issued as preferred stock. Our issued and outstanding shares of common stock as of December 11, 2020 consisted of 15,016,604 shares which were held by 87 shareholders of record, which excludes shareholders whose shares are held in nominee or street name by brokers. To date, there are no issued and outstanding shares of preferred stock.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following description of our capital stock summarizes general terms and provisions that apply to our capital stock. Since this is only a summary, it does not contain all of the information that may be important to you. The summary is subject to and qualified in its entirety by reference to our Third Amended and Restated Charter and our Second Amended and Restated Bylaws, which are incorporated by reference into this prospectus. See &#8220;Where You Can Find More Information.&#8221;</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Common Stock</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For all matters submitted to a vote of shareholders, holders of common stock are entitled to one vote for each share registered in his or her name on our books, and they do not have cumulative voting rights. Each share of the common stock is entitled to share equally with each other share of common stock in dividends from sources legally available therefore, when, as, and if declared by the board of directors and, upon our liquidation or dissolution, whether voluntary or involuntary, to share equally in the assets that are available for distribution to the holders of the common stock. We have not paid any cash dividends since our inception. Holders of our common stock have no preemptive, subscription, redemption or conversion rights. The board of directors is authorized to issue additional shares of common stock within the limits authorized by our Third Amended and Restated Charter and without shareholder action.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Preferred Stock</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares of preferred stock may be issued from time to time in one or more classes or series, each such class or series to be so designated as to distinguish the shares thereof from the shares of all other series and classes. The board of directors is authorized to divide preferred stock into classes or series and to fix and determine the relative rights, preferences, qualifications and limitations of the shares of any class or series so established. The number of shares of Preferred Stock the Company may offer is up to 20,000,000 and those shares can be one or more classes or series.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has designated 3 million shares of Preferred Stock as Series A (&#8220;Series A&#8221;). A summary of the terms of the Series A is set forth below&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently there are 3 million shares of Series A designated,</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">with a liquidation value of $3.25,</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dividend rate on parity with the common stock,</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">voting rights equal to one vote per share,</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">not redeemable or subject to a sinking fund&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the price at which the preferred stock will be issued will be set by the Company&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rights, preferences, qualifications, limitations and restrictions on the remaining shares of Preferred Stock shall be set by the Company prior to issuance and those terms of any new series or classes of preferred stock will be filed with the SEC. The Company will determine whether the preferred stock is convertible or exchangeable for any other securities, and the terms of any such conversion. All other rights, preferences, qualifications, limitations and restrictions of the preferred stock shall be established by the Company before issuance and filed with the SEC.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we offer to sell preferred stock, our board of directors is authorized to designate and issue shares of preferred stock in one or more series without shareholder approval. Our board of directors would have discretion to determine the rights, preferences, </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">privileges and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges and liquidation preferences, of each series of preferred stock.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms, conditions and provisions of the Series A Preferred Stock are described in Exhibit 4.2.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is not possible to state the actual effect of the issuance of any shares of preferred stock upon the rights of holders of our common stock until the board of directors determines the specific rights of the holders of the preferred stock. However, these effects might include&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">restricting dividends on the common stock&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">diluting the voting power of the common stock&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impairing the liquidation rights of the common stock&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">delaying or preventing a change in control of our company.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Transfer Agent or Registrar</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Continental Stock Transfer &#38; Trust Company is the transfer agent and registrar of our common stock.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Listing</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our common stock is listed on Nasdaq under the symbol &#8220;CPIX.&#8221; On December 10, 2020, the closing price for our common stock, as reported on Nasdaq, was $3.01 per share.</font></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DESCRIPTION OF WARRANTS</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may issue warrants for the purchase of common stock or preferred stock. Warrants may be issued independently or together with common stock or preferred stock offered by any prospectus supplement and may be attached to or separate from any such offered securities. Series of warrants may be issued under a separate warrant agreement entered into between us and a bank or trust company, as warrant agent, all as will be set forth in the prospectus supplement relating to the particular issue of warrants. The warrant agent would act solely as our agent in connection with the warrants and would not assume any obligation or relationship of agency or trust for or with any holders of warrants or beneficial owners of warrants.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summary of certain provisions of the warrants does not purport to be complete and is subject to, and is qualified in its entirety by reference to, all provisions of the warrant agreements.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reference is made to the prospectus supplement relating to the particular issue of warrants offered pursuant to such prospectus supplement for the terms of and information relating to such warrants, including, where applicable&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">number of shares of common stock or preferred stock purchasable upon the exercise of warrants to purchase common stock or preferred stock and the price at which such number of shares of common stock or preferred stock may be purchased upon such exercise&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the date on which the right to exercise such warrants shall commence and the date on which such right shall expire&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States federal income tax consequences applicable to such warrants&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the amount of warrants outstanding as of the most recent practicable date&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any other terms of such warrants.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warrants will be issued in registered form only. The exercise price for warrants will be subject to adjustment in accordance with the applicable prospectus supplement.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each warrant will entitle the holder thereof to purchase such number of shares of common stock or preferred stock at such exercise price as shall in each case be set forth in, or calculable from, the prospectus supplement relating to the warrants, which exercise price may be subject to adjustment upon the occurrence of certain events as set forth in such prospectus supplement. After the close of business on the expiration date, or such later date to which such expiration date may be extended by us, unexercised warrants will become void. The place or places where, and the manner in which, warrants may be exercised shall be specified in the prospectus supplement relating to such warrants.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the exercise of any warrants to purchase common stock or preferred stock, holders of such warrants will not have any of the rights of holders of common stock or preferred stock, as the case may be, purchasable upon such exercise, including the right to receive payments of dividends, if any, on the common stock purchasable upon such exercise, or to exercise any applicable right to vote.</font></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DESCRIPTION OF DEBT SECURITIES</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This section describes the general terms of debt securities to which any prospectus supplement may relate. A prospectus supplement will describe the terms relating to any debt securities to be offered in greater detail, and may provide information that is different from this prospectus. If the information in the prospectus supplement differs with respect to the particular debt securities being offered from this prospectus, you should rely on the information in the prospectus supplement. The debt securities may be issued from time to time in one or more series. The particular terms of each series that are offered by a prospectus supplement will be described in the prospectus supplement.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may conduct a portion of our operations through subsidiaries. Unless the debt securities are guaranteed by our subsidiaries as described below, the rights of our company and our creditors, including holders of the debt securities, to participate in the assets of any subsidiary upon the latter&#8217;s liquidation or reorganization will be subject to the prior claims of the subsidiary&#8217;s creditors, except to the extent that we may ourselves be a creditor with recognized claims against such subsidiary.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The debt securities will be either our senior debt securities or our subordinated debt securities. The senior debt securities and the subordinated debt securities will be issued under separate indentures among us, and any domestic subsidiaries that become guarantors of the debt securities (and are added as co-registrants to the registration statement of which this prospectus supplement forms a part), and a trustee that meets certain requirements and is selected by us (the &#8220;Trustee&#8221;). Senior debt securities will be issued under a &#8220;Senior Indenture&#8221; and subordinated debt securities will be issued under a &#8220;Subordinated Indenture.&#8221; Together, the Senior Indenture and the Subordinated Indenture are called &#8220;Indentures.&#8221;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have summarized selected provisions of the Indentures below. The summary is not complete and is qualified in its entirety by express reference to the provisions of the Indentures. The form of each Indenture has been filed with the SEC as an exhibit to the registration statement of which this prospectus is a part, and you should read the Indentures for provisions that may be important to you. In the summary below, we have included references to article or section numbers of the applicable Indenture so that you can easily locate these provisions. Whenever we refer in this prospectus or in the prospectus supplement to particular article or sections or defined terms of the Indentures, those article or sections or defined terms are incorporated by reference herein or therein, as applicable. The Indentures will be subject to and governed by certain provisions of the Trust Indenture Act of 1939, and we refer you to the Indentures and the Trust Indenture Act for a statement of such provisions. Capitalized terms used in the summary have the meanings specified in the Indentures.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;General</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may offer debt securities under this prospectus. The Indentures do not limit the aggregate amount of debt securities, and we may issue debt securities up to the aggregate principal amount which may be authorized from time to time by the board of directors. The Indentures provide that debt securities in separate series may be issued thereunder from time to time without limitation as to aggregate principal amount. We may specify a maximum aggregate principal amount for the debt securities of any series (Section 301). We will determine the terms and conditions of the debt securities, including the maturity, principal and interest, but those terms must be consistent with the Indenture. The debt securities will be our unsecured obligations.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The subordinated debt securities will be subordinated in right of payment to the prior payment in full of all of our Senior Debt (as defined) as described under &#8220;&#8212;Subordination of Subordinated Debt Securities&#8221; and in the prospectus supplement applicable to any subordinated debt securities. If the prospectus supplement so indicates, the debt securities will be convertible into our common stock (Section 301).</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The applicable prospectus supplement will set forth the price or prices at which the debt securities to be offered will be issued and will describe the following terms of such debt securities&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;the designation, aggregate principal amount and authorized denominations of the debt securities&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;whether the debt securities are senior debt securities or subordinated debt securities and, if subordinated debt securities, the related subordination terms&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;any limit on the aggregate principal amount of the debt securities&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;the dates on which the principal of the debt securities will be payable&#59;</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;the interest rate that the debt securities will bear and the interest payment dates for the debt securities&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)&#160;&#160;&#160;&#160;the places where payments on the debt securities will be payable&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)&#160;&#160;&#160;&#160;any terms upon which the debt securities may be redeemed, in whole or in part, at our option&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)&#160;&#160;&#160;&#160;any sinking fund or other provisions that would obligate us to repurchase or otherwise redeem the debt securities&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)&#160;&#160;&#160;&#160;the portion of the principal amount, if less than all, of the debt securities that will be payable upon declaration of acceleration of the Maturity of the debt securities&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10)&#160;&#160;&#160;&#160;whether the debt securities are defeasible&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11)&#160;&#160;&#160;&#160;any addition to or change in the Events of Default&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12)&#160;&#160;&#160;&#160;whether the debt securities are convertible into our common stock and, if so, the terms and conditions upon which conversion will be effected, including the initial conversion price or conversion rate and any adjustments thereto and the conversion period&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(13)&#160;&#160;&#160;&#160;any addition to or change in the covenants in the Indenture applicable to the debt securities&#59; and</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14)&#160;&#160;&#160;&#160;any other terms of the debt securities not inconsistent with the provisions of the Indenture (Section 301).</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Senior Debt Securities</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The senior debt securities will be our direct-unsecured obligations and will constitute senior indebtedness (in each case as defined in the applicable Supplemental Indenture) ranking on a parity with all of our other unsecured and unsubordinated indebtedness.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Subordination of Subordinated Debt Securities</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The indebtedness evidenced by the subordinated debt securities will, to the extent set forth in the Subordinated Indenture with respect to each series of subordinated debt securities, be subordinate in right of payment to the prior payment in full of all of our Senior Debt, including the senior debt securities, and it may also be senior in right of payment to all of our Subordinated Debt (Article Twelve of the Subordinated Indenture). The prospectus supplement relating to any subordinated debt securities will summarize the subordination provisions of the Subordinated Indenture applicable to that series including&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the applicability and effect of such provisions upon any payment or distribution respecting that series following any liquidation, dissolution or other winding-up, or any assignment for the benefit of creditors or other marshaling of assets or any bankruptcy, insolvency or similar proceedings&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the applicability and effect of such provisions in the event of specified defaults with respect to any Senior Debt, including the circumstances under which and the periods in which we will be prohibited from making payments on the subordinated debt securities&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the definition of Senior Debt applicable to the subordinated debt securities of that series and, if the series is issued on a senior subordinated basis, the definition of Subordinated Debt applicable to that series.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The prospectus supplement will also describe as of a recent date the approximate amount of Senior Debt to which the subordinated debt securities of that series will be subordinated.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The failure to make any payment on any of the subordinated debt securities by reason of the subordination provisions of the Subordinated Indenture described in the prospectus supplement will not be construed as preventing the occurrence of an Event of Default with respect to the subordinated debt securities arising from any such failure to make payment.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The subordination provisions described above will not be applicable to payments in respect of the subordinated debt securities from a defeasance trust established in connection with any legal defeasance or covenant defeasance of the subordinated debt securities as described under &#8220;&#8212;Legal Defeasance and Covenant Defeasance.&#8221;</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Form, Exchange and Transfer</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The debt securities of each series will be issuable only in fully registered form, without coupons, and, unless otherwise specified in the applicable prospectus supplement, only in denominations of $1,000 and integral multiples thereof (Section 302).</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the option of the Holder, subject to the terms of the applicable Indenture and the limitations applicable to Global Securities, debt securities of each series will be exchangeable for other debt securities of the same series of any authorized denomination and of a like tenor and aggregate principal amount (Section 305).</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the terms of the applicable Indenture and the limitations applicable to Global Securities, debt securities may be presented for exchange as provided above or for registration of transfer (duly endorsed or with the form of transfer endorsed thereon duly executed) at the office of the Security Registrar or at the office of any transfer agent designated by us for such purpose. No service charge will be made for any registration of transfer or exchange of debt securities, but we may require payment of a sum sufficient to cover any tax or other governmental charge payable in that connection. Such transfer or exchange will be effected upon the Security Registrar or such transfer agent, as the case may be, being satisfied with the documents of title and identity of the person making the request. The Security Registrar and any other transfer agent initially designated by us for any debt securities will be named in the applicable prospectus supplement (Section 305). We may at any time designate additional transfer agents or rescind the designation of any transfer agent or approve a change in the office through which any transfer agent acts, except that we will be required to maintain a transfer agent in each Place of Payment for the debt securities of each series (Section 1002).</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the debt securities of any series (or of any series and specified tenor) are to be redeemed in part, we will not be required to (1) issue, register the transfer of or exchange any debt security of that series (or of that series and specified tenor, as the case may be) during a period beginning at the opening of business 15 days before the day of mailing of a notice of redemption of any such debt security that may be selected for redemption and ending at the close of business on the day of such mailing or (2) register the transfer of or exchange any debt security so selected for redemption, in whole or in part, except the unredeemed portion of any such debt security being redeemed in part (Section 305).</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Global Securities</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some or all of the debt securities of any series may be represented, in whole or in part, by one or more Global Securities that will have an aggregate principal amount equal to that of the debt securities they represent. Each Global Security will be registered in the name of a Depositary or its nominee identified in the applicable prospectus supplement, will be deposited with such Depositary or nominee or its custodian and will bear a legend regarding the restrictions on exchanges and registration of transfer thereof referred to below and any such other matters as may be provided for pursuant to the applicable Indenture.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any provision of the Indentures or any debt security described in this prospectus, no Global Security may be exchanged in whole or in part for debt securities registered, and no transfer of a Global Security in whole or in part may be registered, in the name of any person other than the Depositary for such Global Security or any nominee of such Depositary unless&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;the Depositary has notified us that it is unwilling or unable to continue as Depositary for such Global Security or has ceased to be qualified to act as such as required by the applicable Indenture, and in either case we fail to appoint a successor Depositary within 90 days&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;an Event of Default with respect to the debt securities represented by such Global Security has occurred and is continuing and the Trustee has received a written request from the Depositary to issue certificated debt securities&#59; or</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;other circumstances exist, in addition to or in lieu of those described above, as may be described in the applicable prospectus supplement.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All debt securities issued in exchange for a Global Security or any portion thereof will be registered in such names as the Depositary may direct (Sections 205 and 305).</font></div><div><font><br></font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As long as the Depositary, or its nominee, is the registered holder of a Global Security, the Depositary or such nominee, as the case may be, will be considered the sole owner and Holder of such Global Security and the debt securities that it represents for all purposes under the debt securities and the applicable Indenture (Section 308). Except in the limited circumstances referred to above, owners of beneficial interests in a Global Security will not be entitled to have such Global Security or any debt securities that it represents registered in their names, will not receive or be entitled to receive physical delivery of certificated debt securities in exchange for those interests and will not be considered to be the owners or Holders of such Global Security or any debt securities that is represents for any purpose under the debt securities or the applicable Indenture. All payments on a Global Security will be made to the Depositary or its nominee, as the case may be, as the Holder of the security. The laws of some jurisdictions require that some purchasers of debt securities take physical delivery of such debt securities in definitive form. These laws may impair the ability to transfer beneficial interests in a Global Security.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ownership of beneficial interests in a Global Security will be limited to institutions that have accounts with the Depositary or its nominee (&#8220;Participants&#8221;) and to persons that may hold beneficial interests through Participants. In connection with the issuance of any Global Security, the Depositary will credit, on its book-entry registration and transfer system, the respective principal amounts of </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">debt securities represented by the Global Security to the accounts of its Participants. Ownership of beneficial interests in a Global Security will be shown only on, and the transfer of those ownership interests will be effected only through, records maintained by the Depositary (with respect to Participants&#8217; interests) or any such Participant (with respect to interests of persons held by such Participants on their behalf). Payments, transfers, exchanges and other matters relating to beneficial interests in a Global Security may be subject to various policies and procedures adopted by the Depositary from time to time. None of us, the Subsidiary Guarantors, the Trustees or the agents of ourself, the Subsidiary Guarantors or the Trustees will have any responsibility or liability for any aspect of the Depositary&#8217;s or any Participant&#8217;s records relating to, or for payments made on account of, beneficial interests in a Global Security, or for maintaining, supervising or reviewing any records relating to such beneficial interests.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Payment and Paying Agents</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise indicated in the applicable prospectus supplement, payment of interest on a debt security on any Interest Payment Date will be made to the Person in whose name such debt security (or one or more Predecessor Securities) is registered at the close of business on the Regular Record Date for such interest (Section 307).</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise indicated in the applicable prospectus supplement, principal of and any premium and interest on the debt securities of a particular series will be payable at the office of such Paying Agent or Paying Agents as we may designate for such purpose from time to time, except that at our option payment of any interest on debt securities in certificated form may be made by check mailed to the address of the Person entitled thereto as such address appears in the Security Register. Unless otherwise indicated in the applicable prospectus supplement, the corporate trust office of the Trustee under the Senior Indenture in the City of New York will be designated as sole Paying Agent for payments with respect to senior debt securities of each series, and the corporate trust office of the Trustee under the Subordinated Indenture in the City of New York will be designated as the sole Paying Agent for payment with respect to subordinated debt securities of each series. Any other Paying Agents initially designated by us for the debt securities of a particular series will be named in the applicable prospectus supplement. We may at any time designate additional Paying Agents or rescind the designation of any Paying Agent or approve a change in the office through which any Paying Agent acts, except that we will be required to maintain a Paying Agent in each Place of Payment for the debt securities of a particular series (Section 1002).</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All money paid by us to a Paying Agent for the payment of the principal of or any premium or interest on any debt security which remain unclaimed at the end of two years after such principal, premium or interest has become due and payable will be repaid to us, and the Holder of such debt security thereafter may look only to us for payment (Section 1003).</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Consolidation, Merger and Sale of Assets</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not consolidate with or merge into, or transfer, lease or otherwise dispose of all or substantially all of our assets to, any Person (a &#8220;successor Person&#8221;), and may not permit any Person to consolidate with or merge into us, unless&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;the successor Person (if any) is a corporation, partnership, trust or other entity organized and validly existing under the laws of any domestic jurisdiction and assumes our obligations on the debt securities and under the Indentures including the due and punctual payment of the principal of, any premium on, and any interest on, all of the outstanding debt securities and the performance of every covenant applicable to be performed or observed by us&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;immediately before and after giving pro forma effect to the transaction, no Event of Default, and no event which, after notice or lapse of time or both, would become an Event of Default, has occurred and is continuing&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;we deliver to the trustee an officer&#8217;s certificate and an opinion of counsel, each stating that such consolidation, merger, conveyance or transfer and such Supplemental Indenture comply with the foregoing provisions relating to such transaction&#59; and</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;several other conditions, including any additional conditions with respect to any particular debt securities specified in the applicable prospectus supplement, are met (Section 801).</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Events of Default</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise specified in the prospectus supplement, each of the following will constitute an Event of Default under the applicable Indenture with respect to debt securities of any series&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;failure to pay principal of or any premium on any debt security of that series when due, whether or not, in the case of subordinated debt securities, such payment is prohibited by the subordination provisions of the Subordinated Indenture&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;failure to pay any interest on any debt securities of that series when due, continued for 30 days, whether or not, in the case of subordinated debt securities, such payment is prohibited by the subordination provisions of the Subordinated Indenture&#59;</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;failure to deposit any sinking fund payment, when due, in respect of any debt security of that series, whether or not, in the case of subordinated debt securities, such deposit is prohibited by the subordination provisions of the Subordinated Indenture&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;failure to perform or comply with the provisions described under &#8220;&#8212;Consolidation, Merger and Sale of Assets&#8221;&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;failure to perform any of our other covenants in such Indenture (other than a covenant included in such Indenture solely for the benefit of a series other than that series), continued for 60 days after written notice has been given by the applicable Trustee, or the Holders of at least 25% in principal amount of the Outstanding debt securities of that series, as provided in such Indenture&#59; and</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)&#160;&#160;&#160;&#160;certain events of bankruptcy, insolvency or reorganization affecting us or any Significant Subsidiary.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an Event of Default (other than an Event of Default with respect to Cumberland Pharmaceuticals Inc. described in clause (6) above) with respect to the debt securities of any series at the time Outstanding occurs and is continuing, either the applicable Trustee or the Holders of at least 25% in principal amount of the Outstanding debt securities of that series by notice as provided in the Indenture may declare the principal amount of the debt securities of that series (or, in the case of any debt security that is an Original Issue Discount Security, such portion of the principal amount of such debt security as may be specified in the terms of such debt security) to be due and payable immediately. If an Event of Default with respect to Cumberland Pharmaceuticals Inc. described in clause (6) above with respect to the debt securities of any series at the time Outstanding occurs, the principal amount of all the debt securities of that series (or, in the case of any such Original Issue Discount Security, such specified amount) will automatically, and without any action by the applicable Trustee or any Holder, become immediately due and payable. After any such acceleration, but before a judgment or decree based on acceleration, the Holders of a majority in principal amount of the Outstanding debt securities of that series may, under certain circumstances, rescind and annul such acceleration if all Events of Default, other than the non-payment of accelerated principal (or other specified amount), have been cured or waived as provided in the applicable Indenture (Section 502). For information as to waiver of defaults, see &#8220;&#8212;Modification and Waiver&#8221; below.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A default under other indebtedness of the Company will not be a default under the Indentures and a default under one series of debt securities will not necessarily be a default under another series. Any additions, deletions or other changes to the Events of Default which will apply to a series of debt securities will be described in the prospectus supplement relating to such series of debt securities.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Indentures, the trustee must give to the holders of each series of debt securities notice of all uncured defaults known to it with respect to such series within 90 days after such a default occurs (the term default to include the events specified above without notice or grace periods). However, except in the case of default in the payment of principal of, any premium on, or any interest on any of the debt securities, or default in the payment of any sinking or purchase fund installment or analogous obligations, the trustee shall be protected in withholding such notice if it in good faith determines that the withholding of such notice is in the interests of the holders of the debt securities of such series (Section 602).</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the provisions of the Indentures relating to the duties of the Trustees in case an Event of Default has occurred and is continuing, each Trustee will be under no obligation to exercise any of its rights or powers under the applicable Indenture at the request or direction of any of the Holders, unless such Holders have offered to such Trustee reasonable indemnity (Section 603). Subject to such provisions for the indemnification of the Trustees, the Holders of a majority in principal amount of the Outstanding debt securities of any series will have the right to direct the time, method and place of conducting any proceeding for any remedy available to the Trustee or exercising any trust or power conferred on the Trustee with respect to the debt securities of that series (Section 512).</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No Holder of a debt security of any series will have any right to institute any proceeding with respect to the applicable Indenture, or for the appointment of a receiver or a trustee, or for any other remedy thereunder, unless&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;such Holder has previously given to the Trustee under the applicable Indenture written notice of a continuing Event of Default with respect to the debt securities of that series&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;the Holders of at least 25% in principal amount of the Outstanding debt securities of that series have made written request, and such Holder or Holders have offered reasonable indemnity, to the Trustee to institute such proceeding as trustee&#59; and</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;the Trustee has failed to institute such proceeding, and has not received from the Holders of a majority in principal amount of the Outstanding debt securities of that series a direction inconsistent with such request, within 60 days after such notice, request and offer (Section 507).</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, such limitations do not apply to a suit instituted by a Holder of a debt security for the enforcement of payment of the principal of or any premium or interest on such debt security on or after the applicable due date specified in such debt security or, if applicable, to convert such debt security (Section 508).</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will be required to furnish to each Trustee annually a statement by certain of our officers as to whether or not we, to their knowledge, are in default in the performance or observance of any of the terms, provisions and conditions of the applicable Indenture and, if so, specifying all such known defaults (Section 1004).</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Modification and Waiver</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and the trustee may, without the consent of the holders of the debt securities, enter into one or more Supplemental Indentures for, among others, one or more of the following purposes, provided that in the case of clauses (2), (3), (4) and (6), the interests of the holders of debt securities would not be adversely affected&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;to evidence the succession of another corporation to us, and the assumption by such successor of our obligations under the applicable Indenture and the debt securities of any series&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;to add covenants by us, or surrender any of our rights conferred by the applicable Indenture, for the benefit of the holders of debt securities of any or all series&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;to cure any ambiguity, omission, defect or inconsistency in or make any other provision with respect to questions arising under the applicable Indenture&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;to establish the form or terms of any series of debt securities, including any subordinated securities&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;to evidence and provide for the acceptance of any successor trustee with respect to one or more series of debt securities or to facilitate the administration of the trusts thereunder by one or more trustees in accordance with the applicable Indenture&#59; and</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)&#160;&#160;&#160;&#160;to provide any additional Events of Default (Section 901).</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Modifications and amendments of an Indenture may be made by us, the Subsidiary Guarantors, if applicable, and the applicable Trustee with the consent of the Holders of a majority in principal amount of the Outstanding debt securities of each series affected by such modification or amendment&#59; provided, however, that no such modification or amendment may, without the consent of the Holder of each Outstanding debt security affected thereby&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;change the Stated Maturity of the principal of, or any installment of principal of or interest on, any debt security&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;reduce the principal amount of, or any premium or interest on, any debt security&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;reduce the amount of principal of an Original Issue Discount Security or any other debt security payable upon acceleration of the Maturity thereof&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;change the place or currency of payment of principal of, or any premium or interest on, any debt security&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;impair the right to institute suit for the enforcement of any payment due on or any conversion right with respect to any debt security&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)&#160;&#160;&#160;&#160;modify the subordination provisions in the case of subordinated debt securities, or modify any conversion provisions, in either case in a manner adverse to the Holders of the subordinated debt securities&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)&#160;&#160;&#160;&#160;reduce the percentage in principal amount of Outstanding debt securities of any series, the consent of whose Holders is required for modification or amendment of the Indenture&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)&#160;&#160;&#160;&#160;reduce the percentage in principal amount of Outstanding debt securities of any series necessary for waiver of compliance with certain provisions of the Indenture or for waiver of certain defaults&#59; or</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)&#160;&#160;&#160;&#160;modify such provisions with respect to modification, amendment or waiver (Section 902).</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Holders of a majority in principal amount of the Outstanding debt securities of any series may waive compliance by us with certain restrictive provisions of the applicable Indenture (Section 1009). The Holders of a majority in principal amount of the Outstanding debt securities of any series may waive any past default under the applicable Indenture, except a default in the payment of principal, premium or interest and certain covenants and provisions of the Indenture which cannot be amended without the consent of the Holder of each Outstanding debt security of such series (Section 513).</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the Indentures provides that in determining whether the Holders of the requisite principal amount of the Outstanding debt securities have given or taken any direction, notice, consent, waiver or other action under such Indenture as of any date&#58;</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;the principal amount of an Original Issue Discount Security that will be deemed to be Outstanding will be the amount of the principal that would be due and payable as of such date upon acceleration of maturity to such date&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;if, as of such date, the principal amount payable at the Stated Maturity of a debt security is not determinable (for example, because it is based on an index), the principal amount of such debt security deemed to be Outstanding as of such date will be an amount determined in the manner prescribed for such debt security&#59; and</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;the principal amount of a debt security denominated in one or more foreign currencies or currency units that will be deemed to be Outstanding will be the United States-dollar equivalent, determined as of such date in the manner prescribed for such debt security, of the principal amount of such debt security (or, in the case of a debt security described in clause (1) or (2) above, of the amount described in such clause).</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain debt securities, including those owned by us or any of our other Affiliates, will not be deemed to be Outstanding (Section 101). Except in certain limited circumstances, we will be entitled to set any day as a record date for the purpose of determining the Holders of Outstanding debt securities of any series entitled to give or take any direction, notice, consent, waiver or other action under the applicable Indenture, in the manner and subject to the limitations provided in the Indenture. In certain limited circumstances, the Trustee will be entitled to set a record date for action by Holders. If a record date is set for any action to be taken by Holders of a particular series, only persons who are Holders of Outstanding debt securities of that series on the record date may take such action. To be effective, such action must be taken by Holders of the requisite principal amount of such debt securities within a specified period following the record date. For any particular record date, this period will be 180 days or such other period as may be specified by us (or the Trustee, if it set the record date), and may be shortened or lengthened (but not beyond 180 days) from time to time (Section 104).</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Satisfaction and Discharge</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each Indenture will be discharged and will cease to be of further effect as to all Outstanding debt securities of any series issued thereunder, when&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;either&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;all Outstanding debt securities of that series that have been authenticated (except lost, stolen or destroyed debt securities that have been replaced or paid and debt securities for whose payment money has theretofore been deposited in trust and thereafter repaid to us) have been delivered to the Trustee for cancellation&#59; or</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;all outstanding debt securities of that series that have not been delivered to the Trustee for cancellation have become due and payable or will become due and payable at their Stated Maturity within one year or are to be called for redemption within one year under arrangements satisfactory to the Trustee and in any case we have irrevocably deposited with the Trustee as trust funds money in an amount sufficient, without consideration of any reinvestment of interest, to pay the entire indebtedness of such debt securities not delivered to the Trustee for cancellation, for principal, premium, if any, and accrued interest to the Stated Maturity or redemption date&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;we have paid or caused to be paid all other sums payable by us under the Indenture with respect to the debt securities of that series&#59; and</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;we have delivered an Officers&#8217; Certificate and an Opinion of Counsel to the Trustee stating that all conditions precedent to satisfaction and discharge of the Indenture with respect to the debt securities of that series have been satisfied (Article Four).</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Legal Defeasance and Covenant Defeasance</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If and to the extent indicated in the applicable prospectus supplement, we may elect, at our option at any time, to have the provisions of Section 1502, relating to defeasance and discharge of indebtedness, which we call &#8220;legal defeasance&#8221; or Section 1503, relating to defeasance of certain restrictive covenants applied to the debt securities of any series, or to any specified part of a series, which we call &#8220;covenant defeasance&#8221; (Section 1501).</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Defeasance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Indentures provide that, upon our exercise of our option (if any) to have Section 1502 applied to any debt securities, we will be discharged from all our obligations, and, if such debt securities are subordinated debt securities, the provisions of the Subordinated Indenture relating to subordination will cease to be effective, with respect to such debt securities (except for certain obligations to convert, exchange or register the transfer of debt securities, to replace stolen, lost or mutilated debt securities, to maintain paying agencies and to hold moneys for payment in trust) upon the deposit in trust for the benefit of the Holders of such debt securities of money or United States Government Obligations, or both, which, through the payment of principal and interest in respect thereof in accordance with their terms, will provide money in an amount sufficient to pay the principal of and any </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">premium and interest on such debt securities on the respective Stated Maturities in accordance with the terms of the applicable Indenture and such debt securities. Such defeasance or discharge may occur only if, among other things&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;we have delivered to the applicable Trustee an Opinion of Counsel to the effect that we have received from, or there has been published by, the United States Internal Revenue Service a ruling, or there has been a change in tax law, in either case to the effect that Holders of such debt securities will not recognize gain or loss for federal income tax purposes as a result of such deposit and legal defeasance and will be subject to federal income tax on the same amount, in the same manner and at the same times as would have been the case if such deposit and legal defeasance were not to occur&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;no Event of Default or event that with the passing of time or the giving of notice, or both, shall constitute an Event of Default shall have occurred and be continuing at the time of such deposit or, with respect to any Event of Default described in clause (6) under &#8220;&#8212;Events of Default,&#8221; at any time until 121 days after such deposit&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;such deposit and legal defeasance will not result in a breach or violation of, or constitute a default under, any agreement or instrument to which we are a party or by which we are bound&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;in the case of subordinated debt securities, at the time of such deposit, no default in the payment of all or a portion of principal of (or premium, if any) or interest on any of our Senior Debt shall have occurred and be continuing, no event of default shall have resulted in the acceleration of any of our Senior Debt and no other event of default with respect to any of our Senior Debt shall have occurred and be continuing permitting after notice or the lapse of time, or both, the acceleration thereof&#59; and</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (5)&#160;&#160;&#160;&#160;we have delivered to the Trustee an Opinion of Counsel to the effect that such deposit shall not cause the Trustee or the trust so created to be subject to the Investment Company Act of 1940 (Sections 1502 and 1504).</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Covenant Defeasance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Indentures provide that, upon our exercise of our option (if any) to have Section 1503 applied to any debt securities, we may omit to comply with certain restrictive covenants (but not to conversion, if applicable), including those that may be described in the applicable prospectus supplement, the occurrence of certain Events of Default, which are described above in clause (5) (with respect to such restrictive covenants) and clause (6) (with respect only to Significant Subsidiaries) under &#8220;Events of Default&#8221; and any that may be described in the applicable prospectus supplement, will not be deemed to either be or result in an Event of Default and, if such debt securities are subordinated debt securities, the provisions of the Subordinated Indenture relating to subordination will cease to be effective, in each case with respect to such debt securities. In order to exercise such option, we must deposit, in trust for the benefit of the Holders of such debt securities, money or United States Government Obligations, or both, which, through the payment of principal and interest in respect thereof in accordance with their terms, will provide money in an amount sufficient to pay the principal of and any premium and interest on such debt securities on the respective Stated Maturities in accordance with the terms of the applicable Indenture and such debt securities. Such covenant defeasance may occur only if we have delivered to the applicable Trustee an Opinion of Counsel that in effect says that Holders of such debt securities will not recognize gain or loss for federal income tax purposes as a result of such deposit and covenant defeasance and will be subject to federal income tax on the same amount, in the same manner and at the same times as would have been the case if such deposit and covenant defeasance were not to occur, and the requirements set forth in clauses (2), (3), (4) and (5) above are satisfied. If we exercise this option with respect to any debt securities and such debt securities were declared due and payable because of the occurrence of any Event of Default, the amount of money and United States Government Obligations so deposited in trust would be sufficient to pay amounts due on such debt securities at the time of their respective Stated Maturities but may not be sufficient to pay amounts due on such debt securities upon any acceleration resulting from such Event of Default. In such case, we would remain liable for such payments (Sections 1503 and 1504).</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we exercise either our legal defeasance or covenant defeasance option, any Subsidiary Guarantees will terminate (Section 1304).</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Notices</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notices to Holders of debt securities will be given by mail to the addresses of such Holders as they may appear in the Security Register (Sections 101 and 106).</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Title</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, the Subsidiary Guarantors, the Trustees and any agent of us, the Subsidiary Guarantors or a Trustee may treat the Person in whose name a</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">debt security is registered as the absolute owner of the debt security (whether or not such debt security may be overdue) for the purpose of making payment and for all other purposes (Section 308).</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Governing Law</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Indentures and the debt securities will be governed by, and construed in accordance with, the law of the State of New York (Section 112).</font></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DESCRIPTION OF UNITS</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may issue units comprised of common stock, preferred stock, warrants and other securities in any combination. We may issue units in such amounts and in as many distinct series as we wish. This section outlines certain provisions of the units that we may issue. If we issue units, they will be issued under one or more unit agreements to be entered into between us and a bank or other financial institution, as unit agent. The information described in this section may not be complete in all respects and is qualified entirely by reference to the unit agreement with respect to the units of any particular series. The specific terms of any series of units offered will be described in the applicable prospectus supplement. If so described in a particular supplement, the specific terms of any series of units may differ from the general description of terms presented below. We urge you to read any prospectus supplement related to any series of units we may offer, as well as the complete unit agreement and unit certificate that contain the terms of the units. If we issue units, forms of unit agreements and unit certificates relating to such units will be incorporated by reference as exhibits to the registration statement, which includes this prospectus. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each unit that we may issue will be issued so that the holder of the unit is also the holder of each security included in the unit. Thus, the holder of a unit will have the rights and obligations of a holder of each included security. The unit agreement under which a unit is issued may provide that the securities included in the unit may not be held or transferred separately, at any time or at any time before a specified date. The applicable prospectus supplement may describe&#58;</font></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;the designation and terms of the units and of the securities comprising the units, including whether and under what circumstances those securities may be held or transferred separately&#59;  </font></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;any provisions of the governing unit agreement&#59;  </font></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;the price or prices at which such units will be issued&#59;  </font></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;the applicable U.S. federal income tax considerations relating to the units&#59;  </font></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;any provisions for the issuance, payment, settlement, transfer or exchange of the units or of the securities comprising the units&#59; and  </font></div><div style="margin-bottom:10pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;any other terms of the units and of the securities comprising the units. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provisions described in this section, as well as those described under &#34;Description of Common Stock&#34;, &#34;Description of Preferred Stock,&#34; and &#34;Description of Warrants&#34; will apply to the securities included in each unit, to the extent relevant and as may be updated in any prospectus supplements. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuance in Series </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may issue units in such amounts and in as many distinct series as we wish. This section summarizes terms of the units that apply generally to all series. Most of the financial and other specific terms of your series will be described in the applicable prospectus supplement. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unit Agreements </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will issue the units under one or more unit agreements to be entered into between us and a bank or other financial institution, as unit agent. We may add, replace or terminate unit agents from time to time. We will identify the unit agreement under which each series of units will be issued and the unit agent under that agreement in the applicable prospectus supplement. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following provisions will generally apply to all unit agreements unless otherwise stated in the applicable prospectus supplement&#58; </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Modification without Consent </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and the applicable unit agent may amend any unit or unit agreement without the consent of any holder&#58;</font></div><div style="margin-bottom:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;to cure any ambiguity in any provisions of the governing unit agreement that differ from those described below&#59;  </font></div><div style="margin-bottom:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;to correct or supplement any defective or inconsistent provision&#59; or  </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;to make any other change that we believe is necessary or desirable and will not adversely affect the interests of the affected holders in any material respect. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not need any approval to make changes that affect only units to be issued after the changes take effect. We may also make changes that do not adversely affect a particular unit in any material respect, even if they adversely affect other units in a material respect. In those cases, we do not need to obtain the approval of the holder of the unaffected unit&#59; we need only obtain any required approvals from the holders of the affected units. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Modification with Consent </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not amend any particular unit or a unit agreement with respect to any particular unit unless we obtain the consent of the holder of that unit, if the amendment would&#58;</font></div><div style="margin-bottom:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;impair any right of the holder to exercise or enforce any right under a security included in the unit if the terms of that security require the consent of the holder to any changes that would impair the exercise or enforcement of that right&#59; or  </font></div><div style="margin-bottom:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;reduce the percentage of outstanding units or any series or class the consent of whose holders is required to amend that series or class, or the applicable unit agreement with respect to that series or class, as described below. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any other change to a particular unit agreement and the units issued under that agreement would require the following approval&#58;</font></div><div style="margin-bottom:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;If the change affects only the units of a particular series issued under that agreement, the change must be approved by the holders of a majority of the outstanding units of that series&#59; or  </font></div><div style="margin-bottom:10pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;If the change affects the units of more than one series issued under that agreement, it must be approved by the holders of a majority of all outstanding units of all series affected by the change, with the units of all the affected series voting together as one class for this purpose. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These provisions regarding changes with majority approval also apply to changes affecting any securities issued under a unit agreement, as the governing document. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In each case, the required approval must be given by written consent. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unit Agreements Will Not Be Qualified under Trust Indenture Act </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No unit agreement will be qualified as an indenture, and no unit agent will be required to qualify as a trustee, under the Trust Indenture Act. Therefore, holders of units issued under unit agreements will not have the protections of the Trust Indenture Act with respect to their units. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mergers and Similar Transactions Permitted&#59; No Restrictive Covenants or Events of Default </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unit agreements will not restrict our ability to merge or consolidate with, or sell our assets to, another corporation or other entity or to engage in any other transactions. If at any time we merge or consolidate with, or sell our assets substantially as an entirety to, another corporation or other entity, the successor entity will succeed to and assume our obligations under the unit agreements. We will then be relieved of any further obligation under these agreements. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unit agreements will not include any restrictions on our ability to put liens on our assets, including our interests in our subsidiaries, nor will they restrict our ability to sell our assets. The unit agreements also will not provide for any events of default or remedies upon the occurrence of any events of default. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Governing Law </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unit agreements and the units will be governed by New York law. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Form, Exchange and Transfer </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will issue each unit in global&#8212;i.e., book-entry&#8212;form only. Units in book-entry form will be represented by a global security registered in the name of a depositary, which will be the holder of all the units represented by the global security. Those who own beneficial interests in a unit will do so through participants in the depositary's system, and the rights of these indirect owners will be governed solely by the applicable procedures of the depositary and its participants. We will describe book-entry securities, and other terms regarding the issuance and registration of the units in the applicable prospectus supplement. </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each unit and all securities comprising the unit will be issued in the same form. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we issue any units in registered, non-global form, the following will apply to them&#58; </font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The units will be issued in the denominations stated in the applicable prospectus supplement. Holders may exchange their units for units of smaller denominations or combined into fewer units of larger denominations, as long as the total amount is not changed. </font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Holders may exchange or transfer their units at the office of the unit agent. Holders may also replace lost, stolen, destroyed or mutilated units at that office. We may appoint another entity to perform these functions or perform them ourselves.  </font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Holders will not be required to pay a service charge to transfer or exchange their units, but they may be required to pay for any tax or other governmental charge associated with the transfer or exchange. The transfer or exchange, and any replacement, will be made only if our transfer agent is satisfied with the holder's proof of legal ownership. The transfer agent may also require an indemnity before replacing any units.  </font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;If we have the right to redeem, accelerate or settle any units before their maturity, and we exercise our right as to less than all those units or other securities, we may block the exchange or transfer of those units during the period beginning 15 days before the day we mail the notice of exercise and ending on the day of that mailing, in order to freeze the list of holders to prepare the mailing. We may also refuse to register transfers of or exchange any unit selected for early settlement, except that we will continue to permit transfers and exchanges of the unsettled portion of any unit being partially settled. We may also block the transfer or exchange of any unit in this manner if the unit includes securities that are or may be selected for early settlement. </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Only the depositary will be entitled to transfer or exchange a unit in global form, since it will be the sole holder of the unit. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Payments and Notices </font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In making payments and giving notices with respect to our units, we will follow the procedures as described in the applicable prospectus supplement. </font></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PLAN OF DISTRIBUTION</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may sell securities from time to time pursuant to underwritten public offering, negotiated transactions, block trades or a combination of these methods in the United States through underwriters or dealers, directly to purchasers or through agents or in ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers. The securities may be distributed from time to time in one or more transactions&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">at a fixed price or prices, which may be changed&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">at market prices prevailing at the time of sale&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">at prices related to such prevailing market prices&#59; or</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">at negotiated prices.</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent required by applicable law, a prospectus supplement will include the following information&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the terms of the offering&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the names of any underwriters or agents&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the purchase price of the securities and, if the purchase price is not payable in U.S. dollars, the currency or composite currency in which the purchase price is payable&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the net proceeds to us from the sale of the common stock&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any delayed delivery arrangements&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any underwriting discounts, commissions and other items constituting underwriters&#8217; compensation&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the initial public offering price&#59;</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any discounts or concessions allowed or reallowed or paid to dealers&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any commissions paid to agents.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Offers to purchase the securities being offered by this prospectus may be solicited directly. Agents may also be designated to solicit offers to purchase the securities from time to time. Any agent involved in the offer or sale of our securities will be identified in a prospectus supplement.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a dealer is utilized in the sale of the securities being offered by this prospectus, the securities will be sold to the dealer, as principal. The dealer may then resell the securities to the public at varying prices to be determined by the dealer at the time of resale.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an underwriter is utilized in the sale of the securities being offered by this prospectus, an underwriting agreement will be executed with the underwriter at the time of sale and the name of any underwriter will be provided in the prospectus supplement that the underwriter will use to make resales of the securities to the public. In connection with the sale of the securities, we or the purchasers of securities for whom the underwriter may act as agent may compensate the underwriter in the form of underwriting discounts or commissions.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any compensation paid to underwriters, dealers or agents in connection with the offering of the securities, and any discounts, concessions or commissions allowed by underwriters to participating dealers will be provided in the applicable prospectus supplement. Underwriters, dealers and agents participating in the distribution of the securities may be deemed to be underwriters within the meaning of the Securities Act of 1933, as amended, and any discounts and commissions received by them and any profit realized by them on resale of the securities may be deemed to be underwriting discounts and commissions. We may enter into agreements to indemnify underwriters, dealers and agents against civil liabilities, including liabilities under the Securities Act, or to contribute to payments they may be required to make in respect thereof and to reimburse those persons for certain expenses.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any common stock will be listed on the Nasdaq Global Market, but any other securities may or may not be listed on a national securities exchange. To facilitate the offering of securities, certain persons participating in the offering may engage in transactions that stabilize, maintain or otherwise affect the price of the securities. This may include over-allotments or short sales of the securities, which involve the sale by persons participating in the offering of more securities than were sold to them. In these circumstances, these persons would cover such over-allotments or short positions by making purchases in the open market or by exercising their over-allotment option, if any. In addition, these persons may stabilize or maintain the price of the securities by bidding for or purchasing securities in the open market or by imposing penalty bids, whereby selling concessions allowed to dealers participating in the offering may be reclaimed if securities sold by them are repurchased in connection with stabilization transactions. The effect of these transactions may be to stabilize or maintain the market price of the securities at a level above that which might otherwise prevail in the open market. These transactions may be discontinued at any time.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may engage in at the market offerings into an existing trading market in accordance with Rule 415(a)(4) under the Securities Act. In addition, we may enter into derivative transactions with third parties, or sell securities not covered by this prospectus to third parties in privately negotiated transactions. If the applicable prospectus supplement so indicates, in connection with those derivatives, the third parties may sell securities covered by this prospectus and the applicable prospectus supplement, including in short sale transactions. If so, the third party may use securities pledged by us or borrowed from us or others to settle those sales or to close out any related open borrowings of stock, and may use securities received from us in settlement of those derivatives to close out any related open borrowings of stock. The third party in such sale transactions will be an underwriter and, if not identified in this prospectus, will be named in the applicable prospectus supplement (or a post-effective amendment). In addition, we may otherwise loan or pledge securities to a financial institution or other third party that in turn may sell the securities short using this prospectus and an applicable prospectus supplement. Such financial institution or other third party may transfer its economic short position to investors in our securities or in connection with a concurrent offering of other securities.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The specific terms of any lock-up provisions in respect of any given offering will be described in the applicable prospectus supplement.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In compliance with the guidelines of the Financial Industry Regulatory Authority, Inc., or FINRA, the maximum consideration or discount to be received by any FINRA member or independent broker dealer may not exceed 8% of the aggregate proceeds of the offering.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The underwriters, dealers and agents may engage in transactions with us, or perform services for us, in the ordinary course of business for which they receive compensation.</font></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LEGAL MATTERS</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The validity of the securities will be passed upon for us by Baker, Donelson, Bearman, Caldwell &#38; Berkowitz, PC. Legal counsel to any underwriters may pass upon legal matters for such underwriters.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXPERTS</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements and schedule of Cumberland Pharmaceuticals Inc. as of December 31, 2019 and 2018, and for each of the three years in the period ended December 31, 2019 incorporated by reference in this prospectus have been so incorporated in reliance on the report of BDO USA, LLP, an independent registered public accounting firm, incorporated herein by reference, given on the authority of said firm as experts in auditing and accounting.</font></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WHERE YOU CAN FIND MORE INFORMATION</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the information requirements of the Exchange Act and, in accordance therewith, file annual, quarterly and special reports, proxy statements and other information with the SEC.  These documents may be accessed through the SEC&#8217;s electronic data gathering, analysis and retrieval system, or EDGAR, via electronic means, including the SEC&#8217;s home page on the Internet (</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.sec.gov</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).  Our SEC filings are also available on our website located at </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.cumberlandpharma.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Information contained on our website is not incorporated by reference into this prospectus and, therefore, is not part of this prospectus or any accompanying prospectus supplement.</font></div><div style="margin-bottom:10pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INFORMATION INCORPORATED BY REFERENCE</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are incorporating by reference in this prospectus the documents that we file with the SEC. This means that we are disclosing important information to you by referring to these filings. The information we incorporate by reference is considered a part of this prospectus, and subsequent information that we file with the SEC will automatically update and supersede this information.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any statement contained in a document incorporated or considered to be incorporated by reference in this prospectus shall be considered to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus or in any other subsequently filed document that is considered to be incorporated by reference in this prospectus modifies or supersedes such statement.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incorporate by reference the following documents that we have filed with the SEC&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annual Report on Form 10-K for the fiscal year ended December 31, 2019, filed on March 20, 2020, including information specifically incorporated by reference into our Form 10-K from our Proxy Statement for our Annual Meeting of Shareholders held on May 5, 2020&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, filed on May 22, 2020, as amended by that Amendment to Quarterly Report on Form 10-Q filed on July 24, 2020&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quarterly Report on Form 10-Q for the quarter ended June 30, 2020, filed on August 14, 2020&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quarterly Report on Form 10-Q for the quarter ended September 30, 2020, filed on November 13, 2020&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current Report on Form 8-K and 8-K&#47;A filed with the SEC on January 3, 2020, January 10, 2020, April 21, 2020, May 1, 2020, May 8, 2020, May 29, 2020, October 9, 2020 and December 10, 2020&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The description of the Company&#8217;s common stock contained in its registration statement on Form 8-A filed on August 1, 2007, and any amendment or report subsequently filed for the purpose of updating such description.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we incorporate by reference into this prospectus (i) all other reports filed pursuant to Section 13(a) or 15(d) of the Exchange Act since December 31, 2019, except for information furnished under Form 8-K which is not deemed filed and not incorporated herein by reference, (ii) all documents filed by us pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of this prospectus and before we have sold all of the common stock to which the prospectus relates or the offering is otherwise terminated and (iii) all documents filed by us pursuant to the Exchange Act after the date of the initial registration statement and prior to effectiveness of the registration statement.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will provide without charge to each person, including any beneficial owner, to whom a copy of this prospectus is delivered, upon written or oral request, a copy of any or all of the information that has been incorporated in this prospectus by reference but not delivered with this prospectus. Requests for copies should be directed to Cumberland Pharmaceuticals Inc., ATTN&#58; Investor Relations, 2525 West End Avenue, Suite 950, Nashville, Tennessee 37203, telephone (615) 255-0068. </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</font></div></div></div><div id="ib5b5c1fb12bd44019bcb194945c93970_70"></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="-sec-extract:summary;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INFORMATION NOT REQUIRED IN PROSPECTUS</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Item 14.&#160;&#160;&#160;&#160;Other Expenses of Issuance and Distribution.*</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth all expenses payable by Cumberland Pharmaceuticals Inc. (sometimes referred to as the &#8220;Company&#8221; in this Part II of the registration statement) in connection with the issuance and distribution of the securities.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:64.166%"><tr><td style="width:1.0%"></td><td style="width:57.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.459%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SEC registration fee</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$10,910.00</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FINRA Fee</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Legal fees and expenses</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting fees and expenses</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transfer agent and registrar fees and expenses</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Printing fees and expenses</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Miscellaneous</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">*</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">$ *</font></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;These fees depend on the securities offered and the number of issuances and cannot be estimated at this time.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Item 15.&#160;&#160;&#160;&#160;Indemnification of Directors and Officers.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under Tennessee law, a corporation shall indemnify a director or officer against expenses, including attorneys&#8217; fees, actually and reasonably incurred by him, to the extent the director or officer has been successful on the merits or otherwise in defense of any action, suit or proceeding. A corporation may indemnify a director or officer who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, against expenses, including attorneys&#8217; fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by him or her in connection with the action, suit or proceeding. Excepted from that immunity are&#58;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a willful failure to deal fairly with the company or its shareholders in connection with a matter in which the director has a material conflict of interest&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a violation of criminal law (unless the director had reasonable cause to believe that his or her conduct was lawful or no reasonable cause to believe that his or her conduct was unlawful)&#59;</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a transaction from which the director derived an improper personal profit&#59; and</font></div><div style="margin-bottom:10pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8729;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">willful misconduct.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Second Amended and Restated Bylaws include an indemnification provision under which we have the power to indemnify our directors, officers and former officers and directors (including heirs and personal representatives) against all costs, charges and expenses actually and reasonably incurred, including an amount paid to settle an action or satisfy a judgment to which the director or officer is made a party by reason of being or having been a director or officer of Cumberland Pharmaceuticals Inc. or any of our subsidiaries.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Second Amended and Restated Bylaws also provide that our directors may cause us to purchase and maintain insurance for the benefit of a person who is or was serving as a director, officer, employee or agent of Cumberland Pharmaceuticals or any of our subsidiaries (including heirs and personal representatives) against a liability incurred by him or her as our director, officer, employee or agent.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;ITEM 16.&#160;&#160;&#160;&#160;Exhibits and Financial Statement Schedules.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) A list of the exhibits required by Item 601 of Regulation S-K to be filed as a part of this registration statement is set forth in the Index to Exhibits on page II-4, which immediately precedes such exhibits.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-1</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;ITEM 17.&#160;&#160;&#160;&#160;Undertakings.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The undersigned registrant hereby undertakes&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective registration statement&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement&#59;</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Provided, however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that&#58;</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Paragraphs (1)(i), (1)(ii) and (1)(iii) of this section do not apply if the registration statement is on Form S-3 and the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;That, for the purposes of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by Section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities&#58;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-2</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:0.1pt;text-align:justify;text-indent:0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)&#160;&#160;&#160;&#160;That, for purposes of determining any liability under the  Securities Act of 1933, each filing of the registrant&#8217;s annual report pursuant to Section 13(a) or Section 15(d) o f the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)&#160;&#160;&#160;&#160;To supplement the prospectus, after the expiration of the subscription period, to set forth the results of the subscription offer the transactions by the underwriters during the subscription period, the amount of unsubscribed securities to be purchased by the underwriters, and the terms of any subsequent reoffering thereof.  If any public offering by the underwriters is to be made on terms differing from those set forth on the cover page of the prospectus, a post-effective amendment will be filed to set forth the terms of such offering&#59;</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)&#160;&#160;&#160;&#160;Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable.  In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act of 1933 and will be governed by the final adjudication of such issue&#59; and</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)&#160;&#160;&#160;&#160;To file an application for the purpose of determining the eligibility of the trustee to act under subsection (a) of Section 310 of the Trust Indenture Act of 1939 in accordance with the rules and regulations prescribed by the Securities and Exchange Commission under Section 305(b)(2) of the Trust Indenture Act of 1939.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-3</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:0.1pt;padding-left:27pt"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO EXHIBITS</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.123%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"> Number</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Description</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1**</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/1087294/000095014407007248/g06286a5exv4w1.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#8212;Specimen form of the Company&#8217;s Common Stock Certificate (Previously filed as Exhibit 4.1 to Form S-1&#47;A filed on August 6,  2007) (File No. 333-142535)</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2**</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/1087294/000119312517372414/d489256dex42.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#8212;Preferred Stock Terms, Rights, and Provisions (filed as Exhibit 4.2 to Amendment No. 1 to Form S-3 filed on December 19, 2017)</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.3**</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/1087294/000119312517335943/d489256dex42.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#8212;Form of Senior Indenture (filed as Exhibit 4.2 to Form S-3 filed on November 7, 2017)</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.4**</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="http://www.sec.gov/Archives/edgar/data/1087294/000119312517335943/d489256dex43.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#8212;Form of Subordinated Indenture (filed as Exhibit 4.3 to Form S-3 filed on November 7, 2017)</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.5*</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Form of Warrant Agreement</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.6*</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Form of Warrant Certificate</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.7*</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Form of Unit</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.1***</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="a2020decs-3exhibit5.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#8212;Opinion of Baker, Donelson, Bearman, Caldwell &#38; Berkowitz, PC</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.1***</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="a2020decs-3exhibit231.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#8212;Consent of BDO USA, LLP, Independent Registered Public Accounting Firm</a></font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.2***</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Consent of Baker, Donelson, Bearman, Caldwell &#38; Berkowitz, PC (included in its legal opinion filed as Exhibit 5.1)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24.1***</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Power of Attorney of the Officers and Directors of Cumberland Pharmaceuticals Inc. (included on the signature page)</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* To be filed by amendment or as an exhibit to a current report on Form 8-K of the registrant.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">** Previously filed</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*** Filed herewith</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">II-4</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:10pt;padding-left:13.5pt;padding-right:13.5pt;text-align:center;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Signatures</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Nashville, Tennessee, on the 11th day of December 2020.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CUMBERLAND PHARMACEUTICALS INC.</font></div><div style="margin-bottom:10pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BY&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">A.J. Kazimi</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:0.1pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.J. Kazimi, Chairman of the Board and Chief Executive Officer</font></div><div style="margin-bottom:10pt;padding-left:13.5pt;padding-right:13.5pt;text-align:center;text-indent:-27pt"><font><br></font></div><div style="margin-bottom:0.1pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Power of Attorney</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints each of A.J. Kazimi and Michael P. Bonner his or her true and lawful&#160;attorneys-in-fact&#160;and agents, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign, execute and file with the Securities and Exchange Commission and any state securities regulatory board or commission any documents relating to the proposed issuance and registration of the securities offered pursuant to this registration statement on Form&#160;S-3&#160;under the Securities Act of 1933, as amended, including any amendment or amendments relating thereto (and, in addition, any post-effective amendments), with all exhibits and any and all documents required to be filed with respect thereto with any regulatory authority, granting unto said&#160;attorneys-in-fact&#160;and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises in order to effectuate the same as fully to all intents and purposes as he might or could do if personally present, hereby ratifying and confirming all that said&#160;attorneys-in-fact&#160;and agents, or either of them, or their or his substitutes, may lawfully do or cause to be done.</font></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed below by the following persons in the capacities indicated below on the 7th day of December 2020.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:85.000%"><tr><td style="width:1.0%"></td><td style="width:40.403%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.947%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Signature</font></div><div style="text-align:center"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Title</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#47;s&#47; A.J. Kazimi</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chairman of the Board and Chief Executive Officer</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.J. Kazimi</font></div><div style="text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Principal Executive Officer)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#47;s&#47; Michael P. Bonner</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Michael P. Bonner</font></div><div style="text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Principal Financial Officer and Principal Accounting Officer)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#47;s&#47; Joey A. Jacobs</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Joey A. Jacobs</font></div><div style="text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#47;s&#47; Martin E. Cearnal</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director and Chief Commercial Officer</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Martin E. Cearnal</font></div><div style="text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#47;s&#47; Gordon R. Bernard</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gordon R. Bernard, M.D.</font></div><div style="text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#47;s&#47; Jonathan I. Griggs</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jonathan I. Griggs</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:85.000%"><tr><td style="width:1.0%"></td><td style="width:40.403%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.250%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.947%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#47;s&#47; James R. Jones</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">James R. Jones</font></div><div style="text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#47;s&#47; Caroline R. Young</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Caroline R. Young</font></div><div style="text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#47;s&#47; Kenneth J. Krogulski</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kenneth J. Krogulski</font></div><div style="text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#47;s&#47; Joseph C. Galante</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Joseph C. Galante</font></div><div style="text-align:justify"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>a2020decs-3exhibit5.htm
<DESCRIPTION>EX-5.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i15bf68f654a84932a16963460f935d4d_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:12pt;text-align:center"><img alt="image_01a.jpg" src="image_01a.jpg" style="height:29px;margin-bottom:5pt;vertical-align:text-bottom;width:384px"></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BAKER DONELSON CENTER </font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#8226;</font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> SUITE 800 </font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#8226;</font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 211 COMMERCE STREET </font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#8226;</font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> NASHVILLE, TENNESSEE 37201 </font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#8226;</font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 615.726.5600 </font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">&#8226;</font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> bakerdonelson.com</font></div></td></tr></table></div><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Tonya Mitchem Grindon, Shareholder</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Direct Dial</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#58; 615.726.5607</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Direct Fax</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#58; 615.744.5607</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">E-Mail Address</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#58; tgrindon&#64;bakerdonelson.com</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 5.1</font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">December 11, 2020</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Board of Directors </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cumberland Pharmaceuticals Inc. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2525 West End Avenue, Suite 950 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Nashville, Tennessee 37203</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Re&#58; Registration Statement on Form S-3</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Ladies and Gentlemen&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We have acted as counsel for Cumberland Pharmaceuticals Inc., a Tennessee corporation (the &#8220;Company&#8221;), in connection with the preparation and filing of the Company&#8217;s Registration Statement on Form S-3, filed on December 11, 2020 (the &#8220;Registration Statement&#8221;) with the Securities and Exchange Commission (the &#8220;Commission&#8221;) under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), relating to the proposed public offering of up to $100 Million in the aggregate amount of one or more series of the following securities&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:75pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;shares of common stock, no par value of the Company (&#8220;Common Stock&#8221;)&#59; </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:75pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;shares of preferred stock, no par value, of the Company (the &#8220;Preferred Stock&#8221;)&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:75pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;warrants for the purchase of Common Stock, Preferred Stock or Units (as defined below) (the &#8220;Warrants&#8221;)&#59; </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:75pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;debt securities of the Company, which may be issued in one or more series and which may be senior or subordinated (the &#8220;Debt Securities&#8221;), under the form of (i) senior indenture filed as Exhibit 4.2 of the Company&#8217;s registration statement on Form S-3 (No. 333-221402), filed on November 7, 2017 (the &#8220;2017 Registration Statement&#8221;), as such indenture may be supplemented from time to time (the &#8220;Senior Indenture&#8221;)&#59; and (ii) subordinated indenture filed as Exhibit 4.3 of the 2017 Registration Statement,  as such indenture may be supplemented from time to time (the &#8220;Subordinated Indenture&#8221; and, together with the Senior Indenture, the &#8220;Indentures&#8221;)&#59; and</font></div><div style="padding-left:5.35pt;padding-right:6.65pt;text-indent:21.95pt"><font><br></font></div><div style="padding-left:75pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;units comprised of Common Stock, Preferred Stock, and&#47;or Warrants in any combination thereof (the &#8220;Units&#8221;), which may be issued under unit agreements, to be dated on or about the date of the first issuance of the applicable Units thereunder, by and between the Company and a unit agent to be selected by the Company, in the forms that will be filed as exhibits to the Registration Statement, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ALABAMA </font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#8226;</font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> FLORIDA </font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#8226;</font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> GEORGIA </font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#8226;</font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> LOUISIANA </font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#8226;</font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> MARYLAND </font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#8226; </font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">MISSISSIPPI </font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#8226;</font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> SOUTH CAROLINA </font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#8226; </font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">TENNESSEE </font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#8226;</font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </font></div><div><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">TEXAS </font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#8226;</font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> VIRGINIA </font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">&#8226;</font><font style="color:#6c6f70;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> WASHINGTON, D.C.</font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Board of Directors </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cumberland Pharmaceuticals Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">December 11, 2020</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 2</font></div><div><font><br></font></div></div><div style="padding-left:75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">as such agreements may be supplemented from time to time (the Units, the Debt Securities, the Warrants, the Preferred Stock and the Common Stock are collectively referred to as the &#8220;Securities&#8221;)&#59;</font></div><div style="padding-left:5.35pt;padding-right:6.65pt;text-align:justify;text-indent:21.95pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">all of which may be offered and sold by the Company from time to time on a delayed or continuous basis in accordance with Rule 415 promulgated under the Securities Act, as set forth in the prospectus which forms a part of the Registration Statement, and as to be set forth in one or more supplements to the prospectus.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As counsel to the Company, we have examined originals or copies, certified or otherwise identified to our satisfaction, of&#58; (i) the Registration Statement and all exhibits thereto, (ii) the Indentures and (iii) such other agreements, certificates and other instruments and documents as we considered appropriate for purposes of the opinions hereafter expressed.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In making the foregoing examinations, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to original documents submitted to us as certified, conformed or photostatic copies thereof and the authenticity of the originals of such documents.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As to various questions of fact material to the opinions expressed below, we have, without independent third party verification of their accuracy, relied in part, and to the extent we deemed reasonably necessary or appropriate, upon the representations and warranties of the Company contained in such documents, records, certificates, instruments or representations furnished or made available to us by the Company.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of this opinion, we have assumed that (i) the issuance, sale, amount and terms of any Securities of the Company to be offered from time to time under the Registration Statement will have been duly authorized and established by proper action of the Board of Directors of the Company or a duly authorized committee of the Board of Directors (&#8220;Board Action&#8221;) in accordance with the Company&#8217;s Third Amended and Restated Charter (the &#8220;Charter&#8221;), the Second Amended and Restated Bylaws, and applicable provisions of the Tennessee Business Corporation Act (the &#8220;Act&#8221;), in a manner that does not violate any law, government or court-imposed order or restriction or agreement or instrument then binding on the Company or otherwise impair the valid or binding nature of the obligations represented by the applicable Securities&#59; (ii) at the time of offer, issuance and sale of any Securities, the Registration Statement, and any amendments thereto (including post-effective amendments), will have been declared effective under the Securities Act, and no stop order suspending its effectiveness will have been issued and remain in effect&#59; (iii) a prospectus supplement will have been filed with the Commission describing the Securities offered thereby&#59; (iv) all Securities will be issued and sold in compliance with applicable U.S. federal and state securities laws and in the manner stated in the Registration Statement and the applicable prospectus supplement&#59; (v) prior to the issuance of any Securities, a definitive purchase, underwriting or similar agreement with respect to any Securities offered will have been duly authorized and validly executed and delivered by the Company and the other parties thereto&#59; (vi) any Warrants will be issued under one or more warrant agreements, each to be between the Company and a financial institution identified </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Board of Directors </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cumberland Pharmaceuticals Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">December 11, 2020</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 3</font></div><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">therein as warrant agent&#59; (vii) all Securities will be issued and sold in compliance with the Trust Indenture Act of 1939, as amended, and the securities or blue sky laws of various states and in the manner stated in the Registration Statement and the applicable prospectus supplement&#59; (viii) with respect to the Debt Securities, the Trustee under the Indentures (as applicable, the &#8220;Trustee&#8221;) will be qualified pursuant to the Trust Indenture Act of 1939, as amended, at the time the Securities are offered or issued (or such later time as may be permitted pursuant to the rules, regulations, interpretations or positions of the Commission) and a Statement of Eligibility of the Trustee on a Form T-1 has been or will be filed with the Commission with respect to such Trustee&#59; (ix) the Indentures, together with any supplemental indentures relating to a series of Debt Securities to be issued under the Indentures, as applicable, will be duly authorized, executed and delivered by the parties thereto in substantially the form reviewed by us&#59; (x) if being sold by the issuer thereof, the Securities will be delivered against payment of valid consideration therefor and in accordance with the terms of the applicable Board Action authorizing such sale and any applicable underwriting agreement or purchase agreement and as contemplated by the Registration Statement and&#47;or the applicable prospectus supplement&#59; (xi) the Company will remain a Tennessee corporation&#59; (xii) the Securities will not be issued in violation of the ownership limit contained in any provision in the Certificate of Designation to the Charter setting forth the terms of any class or series of Preferred Stock&#59; (xiii) upon the issuance of any Common Stock, including Common Stock which may be issued upon conversion or exercise of any other Securities convertible into or exercisable for Common Stock (&#8220;Common Securities&#8221;), the total number of shares of Common Stock issued and outstanding will not exceed the total number of shares of Common Stock that the Company is then authorized to issue under the Charter&#59; (xiii) upon the issuance of any Securities that are shares of Preferred Stock, including any Preferred Stock which may be issued upon conversion or exercise of any other Securities convertible into or exercisable for Preferred Stock (&#8220;Preferred Securities&#8221;), the total number of shares of Preferred Stock issued and outstanding, and the total number of issued and outstanding shares of the applicable class or series of Preferred Stock designated pursuant to the Charter, will not exceed the total number of shares of Preferred Stock or the number of shares of such class or series of Preferred Stock that the Company is then authorized to issue under the Charter&#59; (xiv) with respect to any Preferred Securities, the Certificate of Designation setting forth the number of shares and the terms of any class or series of Preferred Stock to be issued by the Company will be filed with and accepted for record by the Tennessee Secretary of State prior to their issuance (the &#8220;Preferred Filings&#8221;)&#59; (xv) the terms of the Securities will conform in all material respects to the respective descriptions thereof in the prospectus which is part of the Registration Statement&#59; (xvi) certificates, if required, representing the Securities will be duly executed and delivered and, to the extent required by any applicable agreement, duly authenticated and countersigned&#59; (xvii) the laws of the State of New York will be the governing law with respect to the Indentures, and any warrant agreement&#59; and (xviii) any Securities convertible into or exercisable, exchangeable or redeemable for any other Securities will be duly converted, exercised, exchanged or redeemed in accordance with their terms.</font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To the extent that the obligations of the Company with respect to the Warrants may be dependent upon such matters, we assume for purposes of this opinion that the other party under the warrant agreement for any Warrants, namely the warrant agent, is duly organized, validly existing and in good standing under the laws of its jurisdiction of organization&#59; that such other </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Board of Directors </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cumberland Pharmaceuticals Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">December 11, 2020</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 4</font></div><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">party will be duly qualified to engage in the activities contemplated by such warrant agreement, as applicable&#59; that such warrant agreement will have been duly authorized, executed and delivered by the other party and will constitute the legal, valid and binding obligation of the other party enforceable against the other party in accordance with its terms&#59; that such other party will be in compliance with respect to performance of its obligations under such warrant agreement, as applicable, with all applicable laws and regulations&#59; and that such other party will have the requisite organizational and legal power and authority to perform its obligations under such warrant agreement, as applicable.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To the extent that the obligations of the Company with respect to the Units may be dependent upon such matters, we assume for purposes of this opinion that the other party under the unit agreement for any Units, namely the unit agent, is duly organized, validly existing and in good standing under the laws of its jurisdiction of organization&#59; that such other party will be duly qualified to engage in the activities contemplated by such unit agreement, as applicable&#59; that such unit agreement will have been duly authorized, executed and delivered by the other party and will constitute the legal, valid and binding obligation of the other party enforceable against the other party in accordance with its terms&#59; that such other party will be in compliance with respect to performance of its obligations under such unit agreement, as applicable, with all applicable laws and regulations&#59; and that such other party will have the requisite organizational and legal power and authority to perform its obligations under such warrant agreement, as applicable.</font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">To the extent that the obligations of the Company under the Indentures may be dependent upon such matters, we assume for purposes of this opinion that the Trustee named therein will be duly organized, validly existing, and in good standing under the laws of its jurisdiction of organization&#59; that the Trustee named therein will be duly qualified to engage in the activities contemplated by the Indentures&#59; that the Indentures have been duly authorized, executed and delivered by the Trustee and constitutes the valid and binding obligation of the Trustee named therein enforceable against the Trustee named therein in accordance with its terms&#59; that the Trustee named therein will be in compliance, with respect to acting as a trustee under the Indentures with all applicable laws and regulations&#59; and that the Trustee named therein will have the requisite organizational and legal power and authority to perform its obligations under the Indentures.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Based on the foregoing, and subject to the assumptions, qualifications, limitations, and exceptions set forth herein and having due regard for such legal considerations we deem relevant, we are of the opinion that&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;Upon completion of the Board Action, the Common Securities will be duly authorized and, when and if issued and delivered against payment therefor in accordance with the Registration Statement and the Board Action, will be validly issued, fully paid and nonassessable.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Upon the completion of the Board Action and the Preferred Filings relating to the Preferred Securities, the Preferred Securities will be duly authorized and, when and if issued and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Board of Directors </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cumberland Pharmaceuticals Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">December 11, 2020</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 5</font></div><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">delivered against payment therefor in accordance with the Registration Statement and the Board Action and Preferred Filings, will be validly issued, fully paid and nonassessable.</font></div><div style="padding-left:5.35pt;padding-right:6.65pt;text-align:justify;text-indent:21.95pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;The Warrants, upon completion of the Board Action and the due execution and delivery of a warrant agreement relating thereto on behalf of the Company and the warrant agent named therein and due authentication of the Warrants by such warrant agent, and upon due execution and delivery of the Warrants on behalf of the Company, will constitute valid and binding obligations of the Company, enforceable against the Company in accordance with their terms.</font></div><div style="padding-left:5.35pt;padding-right:6.65pt;text-align:justify;text-indent:21.95pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;Upon due authorization of the Debt Securities by all necessary corporate action of the Company and&#160;the Debt Securities have been executed, issued and delivered for value, pursuant to an applicable underwriting agreement, if any, and in accordance with the terms of the applicable Indenture and any supplemental indenture related thereto and duly authenticated by the Trustee under the applicable Indenture, as contemplated by the applicable prospectus and&#47;or prospectus supplement made part of the Registration Statement, subject to the final terms of the Debt Securities being in compliance with then applicable law, the Debt Securities will constitute valid and binding obligations of the the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:5.35pt;text-align:justify;text-indent:30.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;With respect to any Units offered under the Registration Statement, upon completion of the Board Action and assuming (i) the terms of the Units and of their issuance and sale have been duly established in conformity with the unit agreement and as described in the Registration Statement and the related prospectus supplement(s), and (ii) the Units have been duly executed and delivered by the Company and authenticated by the unit agent pursuant to the unit agreement and delivered against payment therefor, then the Units, when issued and sold in accordance with the applicable unit agreement and duly authorized, executed and delivered purchase, underwriting or similar agreement, will constitute valid and binding obligations of the Company, enforceable against the Company in accordance with their terms.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Our opinion that any document is legal, valid and binding is qualified as to&#58;</font></div><div style="text-align:justify;text-indent:18pt"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;limitations imposed by bankruptcy, insolvency, reorganization, arrangement, fraudulent conveyance, moratorium or other laws relating to or affecting the rights of creditors generally&#59;</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;rights to indemnification and contribution, which may be limited by applicable law or equitable principles&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;general principles of equity, including without limitation concepts of materiality, reasonableness, good faith and fair dealing, and the possible unavailability of specific performance or injunctive relief and limitation of rights of acceleration, regardless of whether such enforceability is considered in a proceeding in equity or at law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The opinions expressed herein are limited to the federal securities law of the United States of America, the Act, and applicable provisions of the laws of the State of New York (but </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Board of Directors </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Cumberland Pharmaceuticals Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">December 11, 2020</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Page 6</font></div><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">not including any laws, statutes, ordinances, administrative decisions, rules or regulations of any political subdivision of the State of New York) in each case as currently in effect. We are expressing no opinion as to the effect of the laws of any other jurisdiction, domestic or foreign.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This opinion (i) is rendered in connection with the filing of the Registration Statement, (ii) is rendered as of the date hereof, and we undertake no, and hereby disclaim any kind of, obligation to advise you of any change or any new developments that might affect any matters or opinions set forth herein, and (iii) is limited to the matters stated herein and no opinions may be inferred or implied beyond the matters expressly stated herein.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We hereby consent to the filing of this opinion as an exhibit to the Registration Statement and to the use of our firm&#8217;s name in the Registration Statement. In giving this consent, we do not admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act and the rules and regulations thereunder.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:187pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Very truly yours, </font></div><div style="padding-left:216pt;text-align:justify"><font><br></font></div><div style="padding-left:187pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">BAKER, DONELSON, BEARMAN, CALDWELL &#38; BERKOWITZ, a professional corporation</font></div><div style="padding-left:187pt;text-align:justify"><font><br></font></div><div style="padding-left:187pt;text-align:justify"><font><br></font></div><div style="padding-left:187pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Tonya Mitchem Grindon&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="padding-left:187pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Tonya Mitchem Grindon </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Authorized Representative</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>a2020decs-3exhibit231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i19014f52be164c529e7fb532d181e17a_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consent of Independent Registered Public Accounting Firm</font></div><div style="margin-top:12pt;text-align:justify"><font><br></font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumberland Pharmaceuticals Inc. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nashville, Tennessee</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement of our report dated March 20, 2020 (except for the effects of presenting discontinued operations discussed in Note 20, as to which the date is December 10, 2020), relating to the consolidated financial statements and schedule of Cumberland Pharmaceuticals Inc. appearing in the Company&#8217;s Current Report on Form 8-K dated December 10, 2020. </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also consent to the reference to us under the caption &#8220;Experts&#8221; in the Prospectus.</font></div><div style="margin-top:12pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; BDO USA, LLP</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nashville, Tennessee</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 11, 2020</font></div><div style="margin-top:12pt;text-align:justify"><font><br></font></div><div style="margin-top:12pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="padding-right:-4.3pt;text-align:justify"><font><br></font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_01a.jpg
<TEXT>
begin 644 image_01a.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M.G\[64_11L?\7 _/#H/[:D]QE]@GZB7>4_ ]I[_LOLR?7@^G3^=K*?HHV/\
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MZD7>?_)C_P!QQ/\ 7T^NA]-+]Y+_ ,G=^?\ "P/SM<OOPA_L+G["GZD7>?\
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MP[#U'85RX^JX: B B B B B B B B B B B B B B B B B B B B B B B
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M-$].\R4EM2_D(TFOQ[D]S;<_+]I'EF-A>/G)7,_C,D]#YO2L!R_R9^FY6N.
MU7?6[MM/*+**X'@!,<]MT;"0/#P[*',C7?Q#/%#(5,1MB:QW-KF4ZADW)D*#
MC.;X_&69?YPEZ;!O*>^4AM1EV*;JUFM/4S)!D23RNPYZ:9GHV_M[NW<>D!DC
M1YX<UWH,]!0KJ3Y./F[C@Z73>5PF3B!-&N?/:S.'11KHI(MO2#.*&E"[:1(E
MJ7U*^"^ZUPXN$<D]=LVL[RT1Z+-9TO6UV]*</L]PBUVP8>-/6,U+G5)(B^>2
M^G<@U(,E'GF,Y@Z-RY#;/(0"1VYLA,3J]0$H94^97P5"K=K#NP\^]#-?+G=,
M9)UI'4F6V:V]B#1MXW/LW3AC:;:R<--S@#L6<+3K3[33[#K;S#S:'67FEI<:
M=:<22VW6G$&:'&W$&1I41F1D?4AF (<*C:"H(>Q\;S'("U[20010@C800=Q'
M2%^@_J_* B B B B B B BZ%=;5U?C=G)I<BV1@5!<PO)]\J;K,,>J[.)[Q'
M:EQ_>8$ZQ8E,>?%?0ZCN07<VM*BZD9&.%-D\=;R&&>X@9*-[72-!%145!((J
M#7S%D%CI+563M6WV-QF0N+)]>&2*WFD8ZA+3PO:PM-' M-#L((.T+B_RXZ5_
M/!J[Z0,3^^P^7PSB/MJV]U9[)<OXAZX_ V6]Z7'V-/RXZ5_/!J[Z0,3^^P?#
M.(^VK;W5GLD^(>N/P-EO>EQ]C3\N.E?SP:N^D#$_OL'PSB/MJV]U9[)/B'KC
M\#9;WI<?8T_+CI7\\&KOI Q/[[!\,XC[:MO=6>R3XAZX_ V6]Z7'V-/RXZ5_
M/!J[Z0,3^^P?#.(^VK;W5GLD^(>N/P-EO>EQ]C3\N.E?SP:N^D#$_OL'PSB/
MMJV]U9[)/B'KC\#9;WI<?8T_+CI7\\&KOI Q/[[!\,XC[:MO=6>R3XAZX_ V
M6]Z7'V-/RXZ5_/!J[Z0,3^^P?#.(^VK;W5GLD^(>N/P-EO>EQ]C3\N.E?SP:
MN^D#$_OL'PSB/MJV]U9[)/B'KC\#9;WI<?8T_+CI7\\&KOI Q/[[!\,XC[:M
MO=6>R3XAZX_ V6]Z7'V-/RXZ5_/!J[Z0,3^^P?#.(^VK;W5GLD^(>N/P-EO>
MEQ]C7:\;S7#<R1+=Q#+<9RMN IE$YS&[ZJO$0ER"<4PB6NKERDQE/I:6:"7V
MFHDGTZ]#'*M[RTNP3:RQRAN_@<UU*[JT)HNHR>#S6$<QN9L[JT=("6":*2(N
M I4MXVMXJ5%:5I45WKLPY"ZM 1 1 1 1 1 1 1?/+EQ8$63.G28\*%"CO2YD
MR6\W'BQ(L=M3TB3)D/*0TQ'8:0:EK49)2DC,S(B'Y<YK&E[R P"I)V  ;R3T
M +Z0PRW$K8(&N?.]P:UK02YSB:!K0*DDDT &TG8%YM^7'2OYX-7?2!B?WV'7
M_#.(^VK;W5GLED_Q#UQ^!LM[TN/L:?EQTK^>#5WT@8G]]@^&<1]M6WNK/9)\
M0]<?@;+>]+C[&GY<=*_G@U=](&)_?8/AG$?;5M[JSV2?$/7'X&RWO2X^QI^7
M'2OYX-7?2!B?WV#X9Q'VU;>ZL]DGQ#UQ^!LM[TN/L:?EQTK^>#5WT@8G]]@^
M&<1]M6WNK/9)\0]<?@;+>]+C[&GY<=*_G@U=](&)_?8/AG$?;5M[JSV2?$/7
M'X&RWO2X^QI^7'2OYX-7?2!B?WV#X9Q'VU;>ZL]DGQ#UQ^!LM[TN/L:?EQTK
M^>#5WT@8G]]@^&<1]M6WNK/9)\0]<?@;+>]+C[&GY<=*_G@U=](&)_?8/AG$
M?;5M[JSV2?$/7'X&RWO2X^QI^7'2OYX-7?2!B?WV#X9Q'VU;>ZL]DGQ#UQ^!
MLM[TN/L:?EQTK^>#5WT@8G]]@^&<1]M6WNK/9)\0]<?@;+>]+C[&N6H]HZSR
M>Q9I\:V+@F0V\A+JV*JCR['[:Q?1':4\^MF# L)$EQ++*#6LTI,DI(S/P(?6
M')8ZYD$5O<0R2G<&O:X[-^P$E<._TIJC%6QO<GC;^VLVD R2V\T; 2: %SV!
MHJ2 *G:=@7-9'EV*8?%8G9;D^/8M"E2/=(TS([JMI(LB5Y:WO=F)%G)BM.R/
M*;4KL29J[4F?3H1C[7%U;6C0^ZDCC830%[@T$]521M7"QN'R^:E=!A[6YNYV
M-XG-AB?*X-J!Q$,:X@5(%3LJ0%T_\N.E?SP:N^D#$_OL.)\,XC[:MO=6>R7<
M_$/7'X&RWO2X^QI^7'2OYX-7?2!B?WV#X9Q'VU;>ZL]DGQ#UQ^!LM[TN/L:?
MEQTK^>#5WT@8G]]@^&<1]M6WNK/9)\0]<?@;+>]+C[&GY<=*_G@U=](&)_?8
M/AG$?;5M[JSV2?$/7'X&RWO2X^QI^7'2OYX-7?2!B?WV#X9Q'VU;>ZL]DGQ#
MUQ^!LM[TN/L:?EQTK^>#5WT@8G]]@^&<1]M6WNK/9)\0]<?@;+>]+C[&GY<=
M*_G@U=](&)_?8/AG$?;5M[JSV2?$/7'X&RWO2X^QI^7'2OYX-7?2!B?WV#X9
MQ'VU;>ZL]DGQ#UQ^!LM[TN/L:Y2MVKJ^Z\[YGV1@5M[MY?O'S;F&/3O=_.\S
MR?.]UL7?*\WRE=O=T[NT^GR&/K'DL=-7LKB!U-]'M-/0*XEUI+55CP^6XS(0
M\5>'CMYF5I2M.)@K2HK3=4=:Y3\.<*_[X8M_M!4_=8^GEEI]5C_?-_;7$^ L
MY]IW?N,GL4_#G"O^^&+?[05/W6'EEI]5C_?-_;3X"SGVG=^XR>Q3\.<*_P"^
M&+?[05/W6'EEI]5C_?-_;3X"SGVG=^XR>Q3\.<*_[X8M_M!4_=8>66GU6/\
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M^<Z*+-7=53B4F1FB3':623(S+H9&)"QF?PF9;Q8J[M[@TK1DC7.'FM!XF^>
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MW:.!YINW.5:]2?*,\ULM!-98?#8&SLYF/8>T;=7$H:X4\5XN(8ZTKM,)!J*
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MD45UIR;=Q:^1/.6=VE23*.UV>69&1]2%AN6VAKW1-M=1WTT4TEPZ,^UAU&\
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M)@\\JS^CN\/R1U[P,TQJ;%2W+_2PRR^2SGP"WNA#,?#1AHL/ABJF9 1 1 1
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M*,U*49F9]1'#G.>XN<27$U).\GK*M=%%'#&V&%K60L:&M:T !H H  -@ &P
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M@6%D70P<'K9G@]K<UV%PF>Z/B%61LW*1@9ZJUH"("("("("("("+"7E[Z?\
MQNYGXY/A[.PR#6YX<'W;']NXQ#A5NP\??81VP27;I8ZY%3QC+M.NL2D1?+4K
MRR:=-+J,0U3H? :MMW,R,+6WO#1L[ !*WJ\;U31ZUU12M*':)SY-]XCF9R2R
M<<^EKZ273_:<4V/G<Y]G,"?'I'7VF1V_MH>"2H'$7LJPT3N5?&?8'$;>&8Z0
MV*R3EGCDE,FDOX\=V/5YCB=@IQS'\MIDNJ</W&VBMF2V^]Q464V]&6HW65]*
M9:ET]?:7S$N'OQ[9&:M<!02,/I7M\#AT;:.!:=H*WZ<I.:.G><6A++7>FC2U
MN6\,L1(,EM<,H)K>2E/&C<=AH!)&62M' ]JQU'0J24!$!$!%+[P4](G/.<6H
M7=R46Y,1U_0QLXN\)DUEMC5S>VZ7Z.OI;!ZP83#FU\-UI]-VA*6U.MF1H,S/
MY!*>C.5U[K'%_"T-W%! )G1D.8YSO%#3780/5;JA4VY^=\;3_(?60T5?X6\R
M.0=81737QSQQ1TE?*P,/$U[@1V1)(:=XV+.7^&]S7]Z_%OHEMOQ]&9?F"N_P
MG'[@[[(H%_Q,L'^2-W_ZA'_5$_AO<U_>OQ;Z);;\?0_,%=_A./W!WV1/\3+!
M_DC=_P#J$?\ 5$_AO<U_>OQ;Z);;\?0_,%=_A./W!WV1/\3+!_DC=_\ J$?]
M47^'/AO<Y)"S:Y6XHMPD*-M#FJ+=M"ED1]B5N)SEU3:%*\#425&1>/0_D'\/
M(*\ILR<5?YEWV1?IORF6!+@'Z1NPVNVF0C)IX!Y**^94>:%UA7PY&["2KMY'
M:L-70^TE8MEJ4FKIX$I1+6:2,_E/H?3_  #C?F$S'V_;?O'KM1\I9H:NW3.6
MI_/VZZ5/^'7Y8MQS56;EX\3)7>DB9GVNR:Z.:#/VU')CZYM'"6DOD+RC(_\
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M9S+?&AQ8*,<0)+QHIVMR2*D/JR ^)$!1SWR6"056! 1 1 1 1 1 1 1 1 1
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MHB4E1&E25$1I4DRZ&1D?@9&0;U_02#4;"%C!M/A1Q)W6S(1LWCMJ;)94GO\
M-NOP/JJ7*/MG_.>5EN/LU.3Q^\_$_+EIZF1'\I$8QS):0TQEP1D;"UD<?5<
M:_\ ?MX7CSG*5-)\\N<&AGM=I;4F8M8F4I%Y3)+!LW5MYC) :>&,[-FY1#\A
M/A[-"Y='F6O'/8V5Z@ONUYR-C&7+<V#@;ZR[EQX;,N0Y#S2E0M2NQ<EV;;&E
M"2,F#5W&J+L[R,PMTTRX&XEM9NAC_;8_ *FDC?-+G_0]=Q^7/RC/,##R,M.9
M6,M,SCZ@.GMP+2[ Z7%H#K:7K#&Q6]2360"E*\/*OT[N5G#MUZ;MK7<B3@Y2
MO=8>T<+>7E&O9:G'C8BE)N8S#4O&Y$YPNC$>XC5\E[Q[&U$7405J70FI=*DO
MR<!-G6@FC\>(]57 583T!X:3T!;'N4O>1Y2<Z&-@TADFMSW!Q.L;D""\;05=
MPQN);,&CTS[=\S&^J<%A ,.4[("("+)#CARXY"<3LH3E&C-DWF(J>D(?N<;-
M[YSPK)TH031M9-B$_P ^CME>[]6VY"V2EQB49L/-+Z*+(,!JC.Z9N?*<-</B
MJ?&9OC?]&P^*[9L!IQ#U)!49\S.3W+GF]BCBM>XR"\#6D1S4X+F#;6L%PRDL
M>W:6!W9OI21CVU"M;\'/6^TER#<J-?<@F:G0NV91-1(UU,L/+U)E\Y7@E-;?
MV;YOX98R5$?;#M7%1S4:4-3GG5I:*RVCN<&'SA98YP-LLF=@<3[0\^!Q-8R?
M6O-.@/)-%J/Y\=Q/77+ILVH^73IM0:095SHFLKD+=OS\+!2Y8WID@ ?2KGP,
M8TO4YJ5)4DE),E)41*2I)D:5),NI&1EX&1D)DWJAA!!H=A"_H+^("("("("(
M"*.3EOZ6O$SEQ#M++(<'BZZV?,\R1'VQK:'!H,E=L%((DO917M,%1YK'<4A!
M._.#"YGE)-#$F.9FL8%J?EQIC5#'23PB#(G:)H@&OK\^*<,@Z^(<5-@<W>K*
M\GN]?S?Y.SQ6N.OWY+2S* V%ZY\T 97= \GM;8BIX>R<(^(UDBDI15"></IO
M;^X-7J'LS@MYKJJUE^ZXQN#%H4HL:G/K[E,5.10W5/RL.R5;2>XHDI:V7^B_
M=)$HFW5(JWK'0&;T=-6[;VV-<:,G8#P$^M<-IC?\Z=AV\+G4--R7(CO,\O.?
M-@6820V.K8F<4^.G<WMV ;Y(7"C;F '9VC ',V=M'$7-#H^Q@RL2@(@(@(@(
MI#_3'X;XYS8Y+P-:YME+6-X+C>/3\ZRZ)#LX4'*\JJZF97PTXQB;,@W)"I<^
M58H5+E-LN%"@MNKZI=-DE9WR\TI;ZOU"W'WD@CLXXS(\ @/>&D#@97;4D^,0
M#PM!.^BKAWI>=63Y&<KY-3X*T-SGKJY9:V[G,<ZWMY)&O=V]P10<+&L(C87#
MM92QNU@?2^#JS4>L](895:\U+A&/8!AE,TEN#18Y ;A1S62$-N39SWMS+6UE
M$V2GYDIQZ5(7[;KBU&9G=#&XO'X>T;8XR&."T8-C6"@\T]+B>EQ))WDDK0%J
MS6&J-=9N;4>L+^YR.;G-72S/+C2I(:T>ECC;6C(XVMC8-C&@;%Z*.>L;0$0$
M0$0$0$0$0$0$0$0$0$7&W%-49#63*6_JJV\I[!KR)]3<08ME63F.Y*_)F0)K
M3T62UWH(^U:%%U(C'SEBBGC,,[6OB<-K7 $'S0=A7)L[V\QUTR^Q\TL%[&:L
MDC<YCVG=5KVD.::=((49N_/1WX)[V9G2F]4,ZARF4V[Y.4:8D(PGW=Y9J<)Q
M>(-,2\!E$;RNJS55$\I/5).I\#*/<WRJT9F@YPMA:W)]7 >SI^XH8CX?$KX0
MK1\ON^?S]T"^.)V7=F<2PBL&2'E-0-E!<$MNV[-U)^$':6G<:J7J#^FKM?@7
MD57.L[)&P].9;-7 Q#:-;5NU;2;=++\H\3RZI.3/3C^3%#C./L)*0]&GQFUN
M,.&MJ2S'K7KGE]D]%3M?([M\3*:,F IXVT\#VU/"^@)&TAP!+34.#=M7=T[S
MVD>\#C9;>UB.-UK9LX[BQ?()#V=0WRBWDX6=M!Q.#7G@:^)[FMD;1\3Y(VQ'
MZLT@(@(L^^ /I_;.YY;(FX_C<Q&'ZVP_W*3LG9DV$<^+C[$_SSKJ>FK/>(9W
MN4W!1'38CDZTTTTVMUYQ"20ES-]$:'R.M,@8+<]ECXJ&64BH:#6C6BHXGNH:
M"H  ))&RM>N\-WB-+=W_ $S'D<FPWNI[WB;9637<#IBRG')(^CNR@CXF\;^%
MSG.(8QKB7%MPGC=Z6'"OC(U!FXOJ:LSK-(;;/=L+;"(N>9,<IE/0IU;&LHB,
M8QB6:C5]LJJZ"X:5&E2E$+48#EOI'3P:^VM6S78_E9J2/KU@$<##X6-:5IEY
MF]['GAS2?)!E<Q+88-Y/]#QY=:0<)]0]S'=O.W=XMQ-**BH *D02E*4DE)$E
M*2)*4I(B2E)%T(B(O B(AG>Y5O))-3M)7]!?Q 1 1 1 1 15Q_B+=25]IIC1
M&\&(I%=8=L:QUK/DLM?;'Z'.\>L,BBG-<2GN5&J[;!NUCN/HARP61>+AB!.?
M&+9)B;+,-'MT5P8B?G9&EPKX Z/9X7'K6RWY-G6%Q::VS^@Y'_T&]QC+U@)V
M"6UF9"[A'KI([JKJ;Q"VOI54B%8%N#0$0$0$5Y3T+ZU,'T\\ E$Z;AW.>;1L
ME(-!)*.IK+IM/Y25$H_,)2:HG.O0O%?3IX=3N/R;CX-"P.KZ>:8^9XY;_FU6
MAOOZW1N.\=D8B*=AC[%E:[ZV[9*^#Z92FW=7I4P(E-4S0$0$0$74LYP+"MFX
MK<8/L3%,?S;#[^-[I<XUD]5#NJ:Q8[DN(*3 GM/,*<8>0EQI9$3C3J4K0:5I
M(RXMY96F1MGV=_$R:U>*.8]H<TCP@[/".H[1M7<8'4&<TMEH<]IN[N+'-6[N
M*.>"1T<C#N-'L(-"*APW.:2UP()"J;>I3Z*MIIFOO=Y<2H=SE6KX")EMF6IW
MWY%SEFO:UEIZ7*N,6FOF[8Y9A]>RV9/,/*>MH+9)<4N6UYSL>LO,#E')B6/S
M.F ^7'-JZ2':Y\0WES#O?&.D&KVC;5PJ6[>>[%WXK36UQ;Z"YP/@M-52%L=M
MD !';WCR0UL<[11EO<O)'"YH;;RFK0V%_ V2O ()6Q] 1 1 1>JZ4W7LGCSL
MS%]N:FR69BV;8E.3+KY\91JC2XZNB)U-<0C43%K16\8U,2XCI&T^RHTF77H9
M=GB,OD,%D(\IC)#'>1.J"-Q'2UP]4UPV.:=A"Q/7.A],<Q]+W>C]7VK+O!7D
M?"]CO3-/J9(W;XY8W4='(WQFN (ZEL!>$7+O">:FA,:W#BB6:RX,SH-A8@4@
MGY.&9U7QX[EO3K49^:[72$2&Y<!]1$;\%]I2B2YYB$7?T?JBSU=A(\K;4;+Z
M65E:F.0 <3?,-0YIZ6D=-0/.]SUY.9SD?S!NM&9?BELOIMG<4HVYM7DB.0=
M>"#'*T>DE8X EO"XY=C*%#B B B B B B B B B B B B BKV_$&<CSP?0N
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MTL'%N[1C''LY0/6RQEDK>GA>*@'8O81VJPQ 1 1 1 1 1 1 1 1 1 1 1 1
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M=J#[<RQOG$?.OEMPW;NVECO,IX0K*XL"M82 B B BPVY4<!^,',2JD,[AUU
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M9H22Z)Y&U\;HY'Y?C*5#2 B B B B B B B B B B B B B B B B B B B
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MHWRU^"=9XOFC8QTM,O;^271&[RJU [)[CZZ6V(8T=5J3YMBX3RM;" B B B
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MM_S5H:[^MTZ?O'9&(@ 06%BP>$&V9)4^?(1Y@"F $IJFB B B B B B B B
MB\XW!J[&-V:LV#J/,X_O.,;&Q&\Q&X2E/5YB-=0'H93XA]R#;GUKSB9$=PC2
MIM]I"B,C(C' RN.M\OC9\7=BMM<1.8[P!PI4>$;P>@@%9-HS5>5T-JS':QPC
MN'*XR\BN(^HNB>'<#NMCP"QXV@M<0005K9LYP'(L V+F&KKN(O\ "S"LUR#
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M?+[G"[&M?Z:6$=%"=KXQTL/C-'I#1H8Z@_>5[DNF^945QK'EG'!BN8&V22$
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MY+ZJY':UFTEJ1IDM35]I=-:6Q7=O7Q9&5)X7M]+-$7%T4E15S"Q[\M1DZA]
M1 1 1 1 1 1 1 1 1 1 1 1 1:[SU&,";UKSHY2XJPQ[M%+<.59+"C%Y9(CP
M,[DISFO89)M2TICLPLC;2V77N)LB)1$KJ143U[9#'ZRR5LT4;Y4]X'4)#V@\
MZC]G@7I![M>H':GY":3RTCN*7X%@@<[;4OM6^2O)K3:70DGH)K2HHL+1B*F]
M=JP7&7<TS;#L.86;;^695CV,LN%W=6W;ZWB5;:R[&9"^J5RB/P;6?^!)_(?)
ML[<W=Y%:#?+(UG[YP'AZUU.?RC,'@KW-2"L=G:33D=8BC=(1M(];UCS1O6SB
MAPXM=#B5\%AN-"@QF(<2,T7:U'BQFDLQV&D_Y+;32"2DOL$0V'L8V-@8P48
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M<4L5KJE_#';9&C8X+QY-&QW : RWN';.%X#8)3XM(I.!LM=<0.MDB B B B
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M<:3*(>=L FT6)#_)7D3O1#V?YZO-\GKDG6/> -JT[+S!7D)VC:&OM[CIW[8
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M7#CXKF("("*P?\.I3^?RBW=D'NIK.LT&_3^^>8HDL?/NP\)F^ZFSYA)6<O\
M!WO)1H4:?(,B-/<9*G/D/%74=Y/3TMEPUZN*6,T\_A^8M=/RDU[V?*K!8[CI
MVNH1)PTW]E9W+>*M-G#VU*5%>+<:;+@PM.M,J B B B B B B B B B B B
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M]WQ%G[,&D/T]-?J]S00;SX_%RS^[?_"D6Q?Y-G]*N=_N^?ORV5/L576YE 1
M1 1 19;<,.8VT>$^Y*K:FNY"K&K?\JLS_ 9DV1%Q[8&+&M9O5-H3).E%LH1N
MJ?K9Y-N.0)9$KM=96^P]E&DM5Y'2&6;DK$\41V2QDD-E9ZT]1&]CJ$M=T$$M
M,/\ .[DMI3GEHJ72>I&B.[;5]I=M:'36D^RDC*TXF.H&S15 ECV5:\1R,OW\
M=.0VLN4FI,7W-J6Y^=\5R6.I+C$A!1[?'KN(2$7&,9#![EJ@7E+)5Y;R.JFW
M$FAYE;C#K3J[M8'.X[4>+CRV,?Q6T@W'8YKAZ9CAT.:=AZ#L():03YZN97+C
M5/*C6%WHG5\'8Y:U=L(-8YHG5,<\+O5Q2MVM.QP-6/:V1KV-]P'<+!$!$!$!
M$!$!$!$!$!$!$!$!$!%1=]<6@;IO44VG8H-!JRS$=57[O:MQ1DY&U]0XL1.$
MOV6U^5C23Z(]GMZ'_*-0IMSB@$6O+F0?RL4+O0B:S_,6^SN(9%U[W;<3;&M+
M.\OX1NW.NY9]E-^V<[]M:C< HC!%RN(LF^%-2F]YC\4*A;$B0Q8<D=(1Y;49
M*S>]P5LO&CGNI-M*E-I8A$XXI?3HVA)J/H1&8R+2,7;:KQD1!(=D+<&G5VK*
M^@*GP*+>>-X;#DMJZ\:YK9(],Y0M+J4X_(I^ ;=]74 '22 -I6QZ%^%YH4!$
M!$!$!$!$!$!$!%&/ZR->_9>FUR6C1S;)QN#K"P5YBC2GR*G=>M[641&25&;A
MQH:^PNG0U="ZEUZB/.:\;I- 9!K=_#"?.;<1./S K2]RNXCM>\WI>66O"9+Y
MFSKDQE[&WSN)PKX*JA$*4+T%H"("("+8=>FY7,5? SB?&CJ=6V[I3#;%1O*0
MI9/W$ K:2DC0ALO*1)FK2V73J2"(C-1]3.]>@(VQ:+QC6UH;.,^>X<1^:=G@
M7G"[S5S)=]X#5\L@ <,Y<LV=4;^S;O)VEK03X:T &Q9MC+U!B B B B B B
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M:BLFDI(C)Y;NY<!J#;<,_%*";M5+ZEX]R"+Y#,1KS=C#] 7KCZAT!_V\3?\
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M?=42&F&&$*=>>=6KH2&VVTFI1GX$1#^.<UC2YQHT"I/@7[BCDFD;#$"Z5[@
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M=V[2W5DO<BVV5FM[E*XBE$M-5 GS'#IJ-E9$7=%H*9$>$R9]5&U'3U,SZF=
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M:[;IC8[F1C!1C9' >8":+U08B:6XQ-K<3'BFDMXW./6YS&DG9LVDK@!QUV"
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M>QF\E-OICVM3[PI3\W$,C5#>=KY!J6I!(7'=5Y[+G6ZFA]:6.L\6+F&C,C$
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M'F20ESW$DDFI).\D])/25Z$888;:%EO;L;';QM#6M: UK6M%&M:T4 :
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M7./_ .J?$A??1WXHXK^S;;ZRQ>:7GO\ IPUG_>O+_P#4+A91C(U%* B B B
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M$75<Z2E>$9DE224E6*Y"E25$1I4DZB81I41]2,C(_$AQKS;9R@[NS=_%*[;
M$C.V1&PB[A^N-6L4&NY>II 1 1 12N^B?A[^5>HMIB:F,<F%A5/LS,+0NAFE
MAAG7.2X_725J2ZTI!,Y!D,(R,B7U5T2:>TS,I,Y0VKKG7EH\"K(63//F=D]H
M/[YS54?ORYF/$]VS-P%W#/?365O'X2;R"9X&PUK##+U;*D&H"O<"YRT#H"("
M("("("("("("("("("("("("("("("("("("("("("("("("("("("("+66[
M=KV*C;&SZJ*;AQ:S8>:U\8W5$MTV(62649DW5DE!*<-MLNXR(B,_L#7IE&"+
M)W,;?2MGD \YY"]1NCKF2\TCBKN6G:RXVV>ZFZKH6.-/!4[%YX. LC0$0$5P
M3X=/]F#=_P"GIW]7N%BU'(?\7+S[M_\ "C6F;Y2;]*N"_N^/ORY5A$3DM="
MB B B B B B B B B B BX/)\9Q_-,<O<0RRG@9!C&3U%C09#16L=$NMN*:V
MB.P;*MG1G"-#\69$?6VM)_*E1CXW%O!=P/M;EC7V\C2US2*AS7"A!'41L7/Q
M>4R.$R5OF<1-);96UF9+#+&2U\<D;@YCV.&T.:X @]86OW]17A?><(N1=_KH
MBFS];Y(E[+]0Y)*^V+M<*G2WFVZJ?)1]K<R'$Y:%0)W@VMTVVY1-MM2FB%(-
M>:2FT?GGV&UUA)X\#SZJ,G<3ZYA\5VZM Z@#@O1%W;.=UASUY:V^I?$CU-;$
M6^1A;L$=RUH)D8W>(;AI$L6\-XG1<3GQ/*P.&%*?T!$!$!%WG66QLNU!L+#-
MH8%:.4V8X'D57E&.V+?<I+%E4RFY3*)#25(*3!DD@VI#*C['V%K;5U2HR'-Q
MU_=8N^BR-D[@NX) ]I\+37;U@[B.D5!70ZITUA]9:<O=*Z@B$^%R%M)!,P]+
M)&EI(.WA<VO$QPVM> X;0%L:>-.^,5Y-:)UGO/#E(13["QF);/5Y/)D.T-ZR
MIROR;&9;J22ER;C610Y4%U1$25K8-2>J5$9WTT_FK;4.&M\S:?2IXPZF_A=N
M>P^%C@6GS%YJN9^@,MRMU]E-!9H$WN.NG1A]*"6(T?!.T=#9H7,E:-X#Z':"
MO<QW*P) 1 1 10%>O;RVD:FT/CW&W#[1<3,M_+E2<P=A22:FU>IL?DL%80W2
M:6B5'1G5\IN$E7BU)@0K%A9&2S(0GSKU.[&86/ 6KJ7=]4OH=HA:14=8[1U&
M]1:V1IWK83\GUR?CU?S N>9N9B#\+IX-%N'-JU^0F!X'"H+3Y+%Q2D>F9+);
M2-(+53?%45NG0$0$0$5A3X>O0",QY ;*Y!V\$G:S3.(-XUBTAU*T^7G.R4S8
M+\Z$LO8=<K,)K+*,^G_)3:MF?RD)TY&807><N,Y**QVD7 P_Z26H)'F1AX/T
M86N;Y1KF&["\O,7RZLY*76;O#/.!TVMEPN#7#H#[E\+V'I-NX=!5P$6F6FA
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MA!!V$$;"#O"\M-G>7>.NXLA82R0WT$C9(Y&.+'QR,<',>QS2'-<UP#FN!!!
M(-0J37JP^F':</LMD[@U'72[+C1F=PAF*PA<JPGZCR&P+O3BE[)=\U]_&+"2
M2_F:Q=4I1$90I*CD)9?FU#YF<NI-*W1RN+:7:>F?L&TF!Q]0X[RPGZ6X_0.\
M:A?O,[HG>HM><V';HS6,K(N:%C"2X^*QF0A9_P#,1-% )V-IY3"T ;YX@(R^
M."& 1*KMH"("("+WOC3R0V?Q2V]C.Y=3W!UV0T#WE3ZR2Y*.ARS'Y#C2K7%,
MH@Q9$95E0VR&D][?<E;3R&WVE-OM-.([O3^?R.F<I'EL8_AG8=H->%[3O8\
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M(7N8]CVEKV/:2US'M< YKFN!#FD @@@BJ^T?M?! 1 1 1 1 1 1 1 1 1 1
M1 1 1 14'?5CY;+Y8\N<PL*.P7*U?JE<G5^LVVW#.'-KZ*<^G(LL901DVXO+
MLD\^0T]VI=56HAMN>+)"E',W4YU-JB5\+JXZVK#%U$-)XG_NWU(._@X =R]!
MW=#Y/MY0\G;*WOXPS567#;Z])'C-?*P=C;GI'D\/ QS:EHF,SF['J,P1XK1(
M"("("+8#>E?Q[;XX\(=-8O*@G!RK-Z=.V\Z2ZSY$M63;#C1+9F)/9,B4W.H,
M716U3A'X]8'B+O\ +;!C :/M+9PI<S,[>3H/'* ZA\+6<##]"O._WLN8KN9?
M/;-Y6*3M,383?!]K0U;V%F71ES#TMEG[:=O\ZI#QG:K>@(@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(J<WQ '&EG7'(?#>0V.UR8N.[XH7*_*#C,=K#6RL$9A0)<Q
M\V^UF.O(\3E5RT)[26_(@RWC4I2E]*I\[]/"PSL6=@;2"]91]-W:QT!/@XV%
MOFEKCMVK=)\GAS0?J7EQ>\N,E(79+3]P'P<1VFRNBY[6BNT]C<-F!-:-9+"P
M  "L 8A%;#$!$!$!%*+Z0W*=7&'F-A)75FJ%KC<BX^I\\0Z^3=?%/(9T=.(9
M'*)PCCL_@]EA1C=DJ[38KY$OVB2M9'(_*W4GQ=U7#VSJ6%W2&3;L'$1P//1X
MKZ5/0TNZRJI]\CE,.:?):^-C$'ZEPH.0M"!5[NQ:?*(6TVGMK?CX6"O',R'8
M2T4OH"Z:\_: B B B BKD?$;+66DN.31+43:]J90M;9*,D*6WB1);6I'7M4I
M"75$1GXD2CZ?*8@3GV3\$6 Z/*7_ ,1;+/DTVM.NM2NH.(8F 5Z:&XVCSZ"O
MF!5(16!;A%80^'3_ &H-W_H$>_6%A0G/D/\ C%>?<7_BQK71\I-^BK!?W@'W
MG<JQWS?X5:PYOZ>L-<YQ&C5655C<NPUIL5J"F5=8#DSK2$IEQR0]%=L*&S\E
MMJSKE.I9F,I2KJA]J.\S/>L-(X[6&*=87@#;EM3%+2KHW]8W5:=@>VM'#J<&
MD:T>1//'57(G6<>I<"YTN)E+67MF7<,5W "?%.QP9*RI=!,&ET;B1XT;Y&/H
M.\@] ;,XQ[8RK3>V:-RERS%YBF_-;3(549!4NN.%5Y/C4Z1'BG:XY=,-FY&D
M$A)^"FW$MO-N-HI1G,'D-.Y.7$Y-G!=1GP\+F]#V$@5:[>#YQH00/0=RZYAZ
M7YIZ0M-:Z0G$^(NV5H:=I#( .."=@+NSFB)H]E3T.:7,<UQ\6'4+-T!$!$!%
M.%Z2/JB2N*>0Q-#[NN),KCAE=LZ[67,E,B=*T[DMHX@G+:&25./G@=O)]NTA
M-H5[J^M4Z.DG%2T2IBY8<QG::G&%S#R<!*[8XU)@>?5#I[-Q].T;CX[=O$'4
M1[X7=3BYMXU^O]"PM9S,M(0'QBC6Y&!@-(W;AY7&W9!*2.-H$$AX1"Z*Z7$E
MQ9\6-.@R8\V%-CLRX<R(\W(BRXLAM+T>3&D,J6T_'?:62D+29I4DR,C,C%MF
MN:]H>P@L(J"-H(.X@](*T@S0RV\KH)VN9.QQ:YK@0YK@:%K@:$$$4(.T'85]
M _2^: B B B B B B B B BJ8?$=P)#>VN,UHHD^ZS-=9U 9,E$:SD5N2U,B
M22D?*E)-VK/0_LF9_P" 5CY]L<,ICI#Z4P2#SP]I/\8+;[\FC<1NTAJFT%>V
M9DK5YZJ/@D#=OFQNKYW6JW(@%;,U(3Z4E:FU]0SBY%4Z;)-9Y/LN\D$LU*IL
M1R2X2UVFI/0I"H)-F?7V25UZ'TZ'G7+2/M==8UM:4F)_>L>[YM**N?>WNC:=
MW'5<H'%7'L92M/IEQ#'7SN.M.FE-BV!@O O.V@(@(@(@(@(@(@(@(L"_5!_N
M_N5/Z+I_^DJP85S&_$?)?<Q_9"L#W5?^XC27]JL_B/6O>%&EZ+T!$!$!%L=N
M$;3K'"_B(P^VXR\SQ@T$T\RZA3;K3K>J<30XVXVLB6AQ"R,C(R(R,NAB_&CP
M1I+%@[",=;?66+S1\]7LDYW:QDC(<QVJLL00:@@W]Q0@](/05D^,B45H"("(
M"("("("+7]>JWMR+N;GSR&R*LFE.H\;RB'K6D6V[Y\5#&M::NPZU5!=+JAR'
M-R6IG2D*09H7[P:DF:3(SI#S+RC<MK:^GC-88Y!$WJ]J:(W4\!>UQ\]>B#NC
MZ.ET3W>].8VZC[._N;5U[*"*.K>R/N8^(;PYL$D3"#M'!0@$44=XP-600$0$
M5POT'N$\_4.K;KE1L.H5!SC=M1%J]<P9T93,^CU&B2U9?/)DZ2'65;'M(\>6
MVDTFE5; AOMK-,E22M3R7T@_%XU^I+YG#>7C0(@1M;!6O%_K2 X?.-80?&*T
MQ]_[GG;ZRU7!RFTY,),#@IG/O'L=5DN0+2SL]E0?(HR^,FM1/+-&X5B!-@H3
MBM=: B B B B B B B B B BHE^LWR0/D!S:SBGJ;#WS"=&1T:?QI++RE1';
M:@DOR<^LDL]"9*4[FLN7"-Y!J\^+7QS[C(DDFF7-G/\ PYJ^:*)U;.S'8,ZN
M)I)D/F]H7-KTAK5OV[DO+/\ -WR,L+V\CX,[GG'(SU'C".5H;:,KOX1;-CEX
M33ADFD%*DDQ/",E;I7^O2FXW?U9N%&J<;LX"(.;9_"7MO8!&UY4DL@SIB+-K
M:V:A22<;FX[B#-96OH,U$4B(X:3Z*Z%=WEK@/B]I&VMY&TO)QV\O7Q2 $ ^%
MK.!A\+2O/)WMN9OYT>>67R=K(9,%CG_!]IMJWL;4N:][3N+9K@SS-.SQ)&@[
M0I&QGJK4@(L%_4BXW%RFX=;@UK K_G#,:^C7GNN&VV4/3#SS"&WKFGKZ_O,D
MM2LFBMR:<U]?9:L5C#=?X#XR:4NL>QO%=M9VD77VD?C- \+Q6/S'E3WW9N9G
MYI^=&&U/<2=GA9)Q:7I)HWR2Z(CD>_K; XLN:=+H6K7I"BZ]&J B B BNN>@
M_P C3V]Q$D:FN9Y2LMX[9&O%B;<<2N6YK_*53;_!Y;_5U3GEQ9*+2K9+L2A$
M:L:(C,^O2W?)?/\ PII8XR5U;JPDX/#V3ZNC)\P\;!X&!:.._P#<M/B;SC;J
M^RCX,/J2V[>H%&B[@X8KIHV4JYI@G=M)+YW'8**;D2^J+("("("("("("("(
M"("("("("+POE#&?F<9^1,2*RY(E2M%[;C1F&DFMU]]_ ,@:99:074UN..*)
M*2+Q,S'3:B:7:?OVM%7&SG '^K<L]Y52QP\T--S2D-B9G\>YQ.P "[A))/4!
MM*UKPU_+TYH"("("+8K>GY D5O!OB/'DD@G'./&IIZ20HEE[O:X946D0S,OD
M6<28@U%_DJZE]@7QT.QT>CL6UV_R"$^<8VD?,*\VG>)N([GGQK&2*O"-29!G
MGQW,C'?PFFG6-JR_&4J&D!$!$!%'UZCG.G%^#6BI^5DY76VW,R;GX_IW#93A
M+^<\B3'3[SDMO$;<1)5B6'-R&Y,TTF@GW5,1"<:7*0XG!]>ZRMM&X9UUXKLI
M+5L$9Z74VO<-_ RH+NL\+:@N!%BN[3R$RO/G7T>(I)#H^R+)LC<M%."&OBP1
MN(X?*+D@LB!KP-$DQ:]L3FF@EF&7Y/L#*\BSC-+N?DF6Y;=6.0Y)?VCWGV%O
M=6TIR;83Y;O1)&[(DO*49))*4D?1)$DB(J2W5U<7US)>7;W274KRY[CM+G.-
M23YI7H4PN&Q>G<1;8'!P1VN'LX&0PQ1BC(XXVAK&-'4&@#;4G>23M66_ KA3
MG/.+>57K?'_?:?"*7W6\VMGC48G8V'8C[P;:B86\DXKV37ZVEQJJ*KN-UXEN
MJ2<>/(6C*-%:1O-8YAN/@JRS91TTE-D;*]'07NW,'2:FG"UQ$/=X+GC@>0^@
MY=39'@FSL_%%86A=1US<4KM \8015#YY!3A;PL![22-KK_6JM68)I/7>):JU
MGC\3&,'PBGC4F/T\,C-+,9@C4[)E/K-3\^SL9*UR)<IY2WY4EUQUQ2EK4H[N
M8W&V6(L(L;CV".SA8&M:.H=)/22=KB=I)).TKSR:MU9G]<ZDO-6ZHN'W6>OI
MG2S2.Z7'<UH&QC&- 9&QH#8V-:QH#6@+T$<Y8Z@(@(@(@(@(@(@(@(@(@(@(
M@(@(@(@(O!.57[+_ "0_0)N#]7N1#I=2?B[?_<4_UIRD'E+^E73/]X,=]^0K
M6RC7^O3>@(@(@(MA#Z7W]W]Q6_1= _TE9B\O+G\1\;]S#]DKSH=ZK_N(U;_:
MK_XC%GH,U5?D!$!$!$!$!$!$!%\LV="K8SLVQF18$-GL\Z7-D,Q8S7F.(:;\
MU]];;3?F.N)2GJ9=5*(B\3'Y>]D;>.0AK!TDT'HKZP03W,H@MF/DF=6C6@N<
M:"IH!4F@!)\ JOY!L(%I&1,K9L2QB.&M+<J#)9EQEJ;4:'"0_'6XTHT+29'T
M/P,N@,>R1O'&0YO6#4?,7]GM[BUE,-TQ\<PWM<TM<*[14$ [0OK'Z7Q0$0$0
M$0$0$0$0$6OE]4J+(A^H+RG:DM+9<7LIV4E"R(C./.HZ:;$=+H9^P_%D(6G_
M )*B%'.8[7,UQD@X4/E%?.+6D>B#5>BONH2QS=W72;XB'-&+#:CK;+(UP\YP
M(/A"P$&$*PJ B BN"?#I_LP;O_3T[^KW"Q:CD/\ BY>?=O\ X4:TS?*3?I5P
M7]WQ]^7*L(B<EKH0$0$0$0$0$0$7BO)+,&-?<>-[YW)D%$9P[3NR\E.0:B2:
M%TN&W-@T3?5I_N>6['2EM)-N*6LR225&9)/J,_="QP5[>N-!%:2OK]#&X^'J
MV;#YBSCEEAI-1\Q\!@(F\;[W-64%.OM;F-AKM&P DDU  J20-JUJ@U^+T\("
M("("*SG\.?H^2]>[]Y'V$3LA0:NITSBDM;:E%)FV4J#F>;I;6HB0VNOCUM$7
M5)J4HI:B/M(O;L1R&P[C-?9^0>(UK8&'K)(DD] "/]]Z.K/Y2C7D3+#3W+.V
M?6>263)7#:^E:QKK:UJ.D/+[K?0#LP=M=EJ(626IM 1 1 1 1 1 1 1 1 1
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ME?1 13D>DSZ6-SRAR.EW[N^F>K...,VR9512V+#K,G=5S523)53":4;:T8#
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M3X=/]F#=_P"GIW]7N%BU'(?\7+S[M_\ "C6F;Y2;]*N"_N^/ORY5A$3DM="
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M=PW#HNR9U\<IX 1X6@E_[E6 [KF@AS&Y[:>P,\?:8R*\%W< ^E["S!N'-?\
M.RNC9">LR@5%:C7N"C*]&" B B B^ZLK9US95]/5QG)EG:SHE;70VNWS9<Z<
M^W%B1FNXTI\Q^0ZE*>ID74Q](XWS2-BC%9'.  ZR30#SROA=75O96LE[=.#+
M6&-SWN.YK& N<X^  $E;,K56!U^K=8:YUG4I:35Z\P3$L'KR82:6?<L4H*^B
MC&V2B)1)4S (RZEU\?'Q&PG&V4>-QUOCHJ=G!"R,>8QH:/V%Y=M6Y^XU7JK)
MZHO*FZR60N+I]=_%<2OE=7SWKOHYJQ] 1 1 1 1 1 1 1 1 1 1 1 1 1 1
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MW"Q:CD/^+EY]V_\ A1K3-\I-^E7!?W?'WY<JPB)R6NA 1 1 1 1 1 1 1 1
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M%R=S9P>N\?);.+CV4[:OM;AH]5!.!P/%*$L/#*P$"2-CC19*C(%&" B B B
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M^<T,=Q"^"8!T3VEK@>D$4(\\%<NPOKK&7T.2L7F.^MY62QO&]KXW!['#PM<
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MJ!;4,F4L86'8:DOOH&-J.';Q74;0T,H;@5!EX;/@L2M5Z B B B B B B B
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M/YM\1,X1N:?%OKD5:Z[/08FCB9:@U\0NE-#+PLF6$L*E" B B B B B B B
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MSKZ6ML;FWFQJVJJ8,NSL[&8ZB/#@5\".Y*FS9;[AI;9C18S2EN+49$E*3,_
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M B B BV.7!W]BKB!_9<X_P#ZI\2%]]'?BCBO[-MOK+%YI>>_Z<-9_P!Z\O\
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MW3J7_6G:_P"L?(Q<7D]^(=K_ #DWUUZT.=^W_N4S'W)8?>4*EN$GJGR B B
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MCN[7G(6NX9+N>Q@&^NV]@E<!3K9$X&NPM)&^@5[<7.6@A 1 1 1 1 1 1 1
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M2*_D6!92P@_<<AHG9*?_ .#,C=[:)T-QQA2D]Q+1CFJ=,8W5F)?B\B*5VLD
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M;1ODS(WG,:OE#3V0ML<":; 2^\(!.X$AKB!TT--Q55(5J6VI3T?#O?MJ[/\
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M-2E*,U*49F9]14-SG/<7.)+B:DG>3UE;S(HHX8VPPM:R%C0UK6@ - %  !L
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M@@BWJ"#M!&Y=<_K4\G_WC]]?3!L+\8AQ_C+J/\(7ON\OLEV?YI>57Y,Z?_\
M3K/["O/LMV?LK/C(\[V'G.:F3AND>6Y;?Y&9.FEI)N$=Q83.CAI807=\O1"?
M\!#@W61R%]_OL\TWT;W/_C$K(L/I73&GMF QMA8BE/Z/;Q0[-NSVMC=FT[/"
M>M=&'"7?("*]/Z'W]W3J7_6G:_ZQ\C%R^3WXAVO\Y-]=>M"'?M_[E,Q]R6'W
ME"I;A)ZI\@(@(@(@(@(@(@(J%_K0_P!Y;R2_\'?U!ZL%+.;7Z0<A_J/O:%>@
M3N1?]L&F/_,?^K7ZBZ$<*UB B BN"?#I_LP;O_3T[^KW"Q:CD/\ BY>?=O\
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MQCJ-DS]FUP]<!%<OI^^:'><KK@MTM'" B B B B B B B B B B B B B B
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MFH]:9"YR69DWR3/XN%M20R-HHR*,$GACC:R-OJ6A>GCL5BJ B B B B B B
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M)\.G^S!N_P#3T[^KW"Q:CD/^+EY]V_\ A1K3-\I-^E7!?W?'WY<JPB)R6NA
M1:\/U(;!^SYY<L),DFR<;W;FM>GRDFE/D5%BJJBF9&I1FX<6$CO/KT-?4^A=
M>@HKK]YDUIDW.W^62#]Z:#Y@7H^[LUM':]W_ $A%%7A."MG[>N1G:.\[B<:>
M"BPF&'J<D!$!$!%/'\/$^PSS7V0VZ\TTY*XPYLQ&0XXA"Y#Z=HZ9DJ982HR-
MYU,:.XX:4]3)#:E?(DS*:>11 U?< D5..DIX?;H#^P"50#Y1Z-[^1N,<QI+6
M:JM2X@5H/(<DVIZAQ$"IZ2!O(5S(6Q6DY 1 1 1 1 1 1 1 1 1 1 1 1 1
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M(;BM[@QZ&@^]+$>#$:BUVPTM-^!*KFHU@XKHE$!?BL5JU=R8RV++KS3A=>V
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MMO)#O-\LN>EL+?3]P;/5;&<4N.N2UMP !5[X2"6W,337QXCQ-%#+'%Q &/\
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M:N?=7^R7Q^(>A_P-BO>EO]C3\N.ZOSP;1^D#+/OL'PQE_MJY]U?[)/B'H?\
M V*]Z6_V-/RX[J_/!M'Z0,L^^P?#&7^VKGW5_LD^(>A_P-BO>EO]C3\N.ZOS
MP;1^D#+/OL'PQE_MJY]U?[)/B'H?\#8KWI;_ &-/RX[J_/!M'Z0,L^^P?#&7
M^VKGW5_LD^(>A_P-BO>EO]C3\N.ZOSP;1^D#+/OL'PQE_MJY]U?[)/B'H?\
M V*]Z6_V-?Y<W;N=U"VG=N[/<;<0IMQMS/LK6AQ"R-*T+0JV-*D*2?0R/P,A
M_#E\L10W5Q3^<?[)?INA=$L<'LP^*#@:@BTMP01TCVM>8#KEE* B B BG9]
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MT^USL-ODCVN=!\\.DQ>$U+.DENT;FNZ3WQ8^91AY<\SYHH=>@!MK=$-CCR
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MR@THJI@K2MMJ B B B B B B B B B B B B B[CKO.\CU=GV%;)Q"8=?E6
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MH"("("+8Y<'?V*N(']ESC_\ JGQ(7WT=^*.*_LVV^LL7FEY[_IPUG_>O+_\
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M%8?_ *K8_P#Z)B#8C9_[I%_-M_BA>63._P#/+S[KF^N.7:1R5U2 B B B B
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M#T\!%..(G?XA(+2=["-I(<M_'=$Y_P#Y\.7O8YR1IU]A^"&^V =NUP/87@
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M\/RSU7_ZOD/ZPG]1WA5^Z!Q<_P#3_J?\4@^)VD?P5C?>T/L$_/OSP_+/5?\
MZOD/ZPG]1WA5^Z!Q<_\ 3_J?\4@^)VD?P5C?>T/L$_/OSP_+/5?_ *OD/ZPG
M]1WA5^Z!Q<_]/^I_Q2#XG:1_!6-][0^P3\^_/#\L]5_^KY#^L)_4=X5?N@<7
M/_3_ *G_ !2#XG:1_!6-][0^P3\^_/#\L]5_^KY#^L)_4=X5?N@<7/\ T_ZG
M_%(/B=I'\%8WWM#[!/S[\\/RSU7_ .KY#^L+P3E)Z<'&'9_'?<.#:SXW:$P/
M8]W@UR> Y7AVH]?8CD%7FE8R5QBY1LBHL<AVU=#GW=>Q&F&RXDW83SK:B4E:
MDGTFI- Z=R."N[/'X^RAOWPN[)\<$3'"0>,RCFL#@"X .H=K21N*D'E1WF.:
M>E>9&%SVJ-3:AR&FH+^/RN"YR%Y<0R6SSV<_%#+,Z-[F1/<^/B!X96L<*$ B
M@:^P_%?>C2678\F.ZXQ(COMK:?8?:6;;K+S3A)<:=:<2:5)41&DRZ&*2N:6D
MM<"' T(/0O0O'(R5C98G!T3@""#4$':""-A!&T$;U^0_*_2 B BN$_#Z\C_P
MZX_YWQSO)_FWVD<C5D&)L.KZ+<UWL"3+L'(T9*G%K?\ F/-F;%;ZB)*6T6D9
M!%]D[4\CL_Y;@YL#,[VZSDXF?S4I)H.OADXB>KC:%ID^44Y9_ ',2PYE6$=,
M?G;;L;@CHO+1K6!SME!VMJ80T;23!*Y6#!.*UU("("("("("("("("("+R[>
M/^Y7<'Z+M@?T3MAUN9_Y1=?<TO\ $<LKT'^/&&_M:T^^(UK.QKW7J%0$0$0$
M6QRX._L5<0/[+G'_ /5/B0OOH[\4<5_9MM]98O-+SW_3AK/^]>7_ .H7"RC&
M1J*5\5E6UUS73ZBW@0K6IM84JMM*NRBL3JZRKIS#D6; GPI3;L:9"F1G5-NM
M.)4AQ"C2HC(S(?B2..6-T4K0Z)P(((J"#L((.P@C80=Z^]M<W-E<QWEG(^&\
MA>U['L<6O8]I#FO8YI#FN:X M<""" 0:JDMZLGICV/$#,G]O:CJYUCQLS>U-
M,=ELI=A)U)D4Y:5?@I>2U-K/\&+"0X94DUY:EF1>YR%&^AIZ74+F;R\DTM=G
M*XMI=I^9VS>3 X^H<?6$_2W'Z!VT NWG=T+O2VW.7"MT;K&6./F=80[2>%C<
MA"T?[Q$VOT]@']*B: /Y:,"-SF0PP")5=M 1 1 12C^EYZA]YP=VP=;E+]E;
M\?-BSXD;9..,*D2EXY-/RHD78^.5Z/,[KJF82E$UEI'?95Z/*,C=:BJ:D?ES
MKN;1V3[.Y+G8.=P$K!4\!W"5@]<T>F ].W9O#:52[U?=OL.?&D?*L2V*'F+C
M8W.LIC1HF;M<ZRF>:>U2&IB<XTAF/'L8^4.O:8YD=!E]!2Y7BMS6Y#C625<"
M\H+ZGF,6%5<4]I&;F5UE73HRW(\N%-BO)<;<0HTJ2HC(Q<Z">"Z@9<VSVR6\
MC0YKFFK7-(J""-A!&T%:"LEC<AALC/B<M#+;92VE?%+%(TLDCD8XM>Q[7 %K
MFN!!!%00N:'U7!0$0$0$0$0$0$0$0$0$0$0$0$0$0$6,'-QUUCA?R[?8<<9>
M9XP;]=9>:6IMUIUO5.6+;<;<09+0XA9$9&1D9&74ACNL"1I+*$;",=<_67J5
M.13&2<[M'1R .8[56)!!%00;^WJ".D'I"UQ(H.O2X@(@(@(MB5Z=O["G$O\
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MGFOV?L'T%N'^34BD&@M2S$'LG9>%H/02VW!< >L!S2?-'6JY@@5;*5-_\/\
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MWT=^*.*_LVV^LL7FEY[_ *<-9_WKR_\ U"X648R-12@(NI9W@F'[/P[)-?;
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M=2\ZKM;3D.0T$O&\9)71;:E$YD%O&3VI4E2NO0C(S(8SK.^&-TGD;RM'-M)
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MIBIS"!%:-RWKF4-DI*53(K?D>>U#MSRTYCQ:HMVXG+/:W4,;? !.T#TS>CC
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M#_\ O%]2?ZK[7_5OD@E#D]^/EK_-3?6G*GW?M_[;,Q]UV'W["KU N4M"" B
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MZ7MHV^33M'SU8HYG^&<'I*F@$M*D: B B B B B B B B B B B B B B B
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M+>#BBMFN'2R:<RO'3Q6HZ-]L@6:6H9 1 1 11C>LE/D5WIL\EI$8TDXY#U=
M4:TDLO=[3=FMJR61$?R*.+,623_R5=#^P([YKO='R_R#F[Z0CSG7$0/S"K2]
MRJWCN>\WI>.6O"'WS]G7'C+U[?X317K&Q4(Q2E>@M 1;,31W^Y73_P"B[7_]
M$ZD;",-_RBU^YHOXC5Y>M>?CQF?[6N_OB1>HCLEBB B B B B B B B B_BD
MI4DTJ(E)41I4E1$:5),NAD9'X&1D&]?T$@U&PA4_/6"]*]6D+"\Y2<>,?/\
M(S;2_?\ 9^$5ZC<5J^]M9Q-JOZ*%V$M.OK>;*02V$*7\T2G.U))A+;3%JQS4
MY;? [WZCP4?_  EQK-&/Y%Q/IFCZDXG=Z@G9XA'#N7[F7>R&N[>#E1S(N/\
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M^G&-)J=K67MX6BF[87NV@5-=M:"E@<3@M=J B B B B B B B B B B B B
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M[/YGF+43\IAB6PZGTIG0VC[FPO8"[9M%M+!(!OKL\J)VBGC;"36EE(6 6L5
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MP#IK&ZP<2? >T%/,*LYBPZU9H"("("("("("*,[U%_38UGSIPIRTCI@89O\
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MF[[P'-";G!S9R^M@7?!DL_96C37Q+.#VN#8?2N>T=M(WHED>LP!E2AE 1 1
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M$L<E_P >(_N:7]@*E'?^_P"W>Y_M6R_CN5W\7"6B9 1 1 1 1 1 1 1 1 1
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MX&T-A@[*P<*.@M(8S^XC:W_(O,)S)S<>IN8N?U)$0Z+(9J^N01N(GN99010
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M:X':""-A!Z"%JER&.O\ $WTV+RL$MMDK>1T<L4K'1R1O::.8]C@'-<TBA:X
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M#Z4$L1H^"=HZ&S0N9*T;P'T.T%>YCN5@2 B B B B B B B B B B B B B
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M"([B$G=)&2=A\5["^-X+'N:;_G%#E+K#F#IG'-R:OL"5!M&_<LCQJ5(8<O\
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M:",O/AIN:/GG&C6CI<0%EFA=&YGF%K#':)T^SCR^2NF0Q["0WB/CR/IM$<3
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M_FJI7?DMFS]V74$I)!AEQ[QX2<E:1T/G2$^: KWPN>M B B B B B B B B
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M7+Z7F9SLP&FC'VF.;>LNKK95HM;0]O,'[P!*&"$$[..5HZ5KQA15>CM 1 1
M16NOA]>),B@Q?.>8&85:F9F:M2];ZD*9&)*OP6K;!E[.,KA*=0KN:N,AKV:N
M.\V:%H^;9B#ZH>(68Y':8=!;S:JNFT?,#%!4>H!]L>/HG ,!'K'C<5J.^44Y
MP1Y'*V')G#2AT-B6WN0X7?R[V$6MNZAWQPO=.]IJ#VT#A1S%9;%@EK 0$0$4
M%?KM<N?R+<<H7'_$[/W?8'(GWRMN?=7NV73ZDJ7&?PL>=[#-3/X83'6:=M+B
M>R3"<L"2?<T(:YSZH^", ,';.I?7]0ZF]L#?3_OS1@KL+3)TA7X[@G)WX[\R
MW\Q,O%Q:=TWPOCXAXLF0D!\G KO\G:'7!(-62BW)%'JE\*E+=P@(KR/H<Z83
MJO@AB>3RXI,7F[,MRG9]@;B"]Z35G*:P[%V%.=A*.&]18JU/91U4E/OZE%T4
MM1"XW)W$_!NBXKAPI->2OF/72O9L'F<+ X?1'K6ASOX:V.K.?]YBX7\5A@K.
M"Q90^+Q\)N9S3UPEN'1.- 3V0&X!3""5%3) 1 1 1 1 1 1 1 1 1 1 1>/<
MA-6P]WZ*V_J"<E)M;(UQF&',N*[".)/O**;"J[!M3OVM$BLLW69#2E>REQI)
MGX$.JSF-9F,-=8I^ZXMWQ^87-(!\T&A'A"S/ESJR;0FOL-K* GCQF3MKDC;X
MS(I6ND8:;:/8',<!M(<0M:C(COQ)#\24RY'DQ7G8\AAU)H=8?96IMYEU"NBD
M.-N)-*B/Q(R&OQS7,<6N%' T(\*]/44D<T;9HB'1/:""-H((J"#U$;0OQ'Y7
M[0$0$4J'H^\KF.+O,#%V<EL"@ZUW2RSJG-WGW2;A54JYGQW,,RB0:S2RTW2Y
M0AEF0^XI*(]=-EN&?AT.2>5>IFZ<U5&+AU,?=CL9*[FEQ'9O/T+Z D[F.<54
M[OF<HY.:W)F[?BX^TU/@W&_M0!5TC8V$7, IM)E@XG,: 2^:*%O2KXHNBM "
M B B B B B B BC.]8B^1CWIQ\DI)N^6]85> T,=M,HHKLA=]M7!JI]ID_Y3
M_9"E.NN-)(S<8;61]$]3*/>:DX@T%D'=+FQM&VE>*:-OG["21T@%6A[F&/=D
M>\MIB("K(Y;N4GAX@!%874@)ZJN:UH<=SBWIH%0;%)UZ#T!$!$!%?%]%>S:L
M/3;X_,I<=<>J96VZR4;O=[+I;IV%/8;;4HS[VFX$]DBZ>">G:7R"Z/*.0/T!
M8@5JTS@^^)3^P0M '?@M76_>;U$\@!DS,>]M.KX-LV$GPE['>;OZ5*@))53D
M!$!$!$!$!$!%40]:OTU$ZGO+7EYHZC-&LLLMB=W%B59$(H^O\ON)A-M9E6,1
MFR;BX;EUA(2W*;,B37VSJ>Q2F9C;46KG-SE]\&3.U3AF?\.E=[>P#9$]Q^F"
MFZ-Y-"/4O.S8\!NX[N.]YXZOL(N3>O+BNJ;.&F.N'NVW=O&VIMGEQJZYMV E
MCM\UNTU ?"Y\M=D00MD2 B B BSHX"<Y]@\%]RQ,WQ\Y=[KO(W(-5M?7?O*D
M0\LQQE]9IFP6W'6XL7+\>3(=>JY:NG8M;C+AG'?>2K,]$ZROM&Y87D%7V$E&
MS15V/9UCH#VU)8[HV@^*XA0+WA>0NG.?>BGX+(\%OJ2V#Y+"\X:NMYB/2N(!
M<ZWFHUL\8W@->T=I&PB^]IG<>N]_ZSQ/;FJLACY-@V9UJ;&GLV4+9>0:7%QY
MM=90WB3(KK>JG,N1Y49TB<8?;4DR\.HNMB<K89O'Q93&O$EG,VK3\P@C>'--
M0X':"*+SYZVT7J3EYJB\T=JVV=:YZQEX)&&A&X%KV.&Q\<C2'QO;4.:X$+T\
M=BL50$0$0$0$0$0$0$0$0$4'GQ >1IIN#-)5=Y$YEV^<"HR;[4+6MN%C>=Y.
MXOVEI6VVVO'T$:TDKHI24F71?4H=YWSB+1K(NF6]C;Z#)'_YO_Q57O\ D[\:
M;WGU/=T\6ST_=RUVBA=-:P#HVDB8[#38">A4K14=;P4!$!$!%=!^'SRM%WPH
MR['EO=96&;ZS&O3',R-35;<8I@E_%?(DM([6I$^PF)(C4M7<TH^I)-)%;7D=
M<B;2$L%?&AO9!3P.9&X'SR7>@M(_RBN(=8\\K/)!OM5]I^V?7K?'<74+AO.T
M,9&=P%'#IJ5.H)E5!T!$!$!$!$!$!$!$!$!$!%#1ZQO/R'Q5TI)U'@%TAO?N
MZZ.?6U!09*"L, P&9YU7?9W))I?O,"?/(GH%(O[6I4PGY+:C."M"HGYK:V9I
MK$'%V+_^-WC"&T.V*,['2'I!.UL>[QJN!\0A77[EO=ZFYM:Y;K'4,!/+W!SL
M?)Q-/!=W;:216K:^*]C/%ENAM C[.)P_I#2(5/0(T'^4GEO>[BLX7O&/\?\
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MMYN/%B18[:GI$F3(>4AIB.PT@U+6HR2E)&9F1$/RYS6-+WD!@%23L  WDGH
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M?V-GE+&;&9&)D^/N(GQ2QO <R2.1I8]CVG8YKVDM<#L()!5^KTT^==!SAT/
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MJ.86=U'<%QFOLQ>3GBWCM;B1X&S8.$$- &P  #8 O8QVJPM 1 1 1 1 1 1
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M?=5Z\M67&9EBN0T:EU^89;%4J/6(3VR8D1;LXE,K*$MZ&N;.O&X&P.!Q;_\
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MG^3&J\/&*SS:>OPP=<@MI'1]#MG:-;6@)IZ7;0K8[B^Z\T2 B B B B B B
MB B B B B B B B@']7STL&.05/<<E^/M!'8WGCU:_.S_#ZN,M+NXJ*LAI-,
MNMBQR4E[8]-#B]C"4H\VXCD4<S4^W&2N$N:7+=N<B?J'!L S,;:RL ^GM W@
M#^5:!LZ7CQ?3!M=A7<V[V,G+J]AY7\Q;ASM!7,H;:7$CA3'2O=Z5[CNLI'.J
M\D\-N^LE!&Z4MIS.M.L.N,/MN,O,N+:>9=0IMUIUM1H<;<;61+0XA9&1D9$9
M&70Q5,@@T.PA;I6/9(P21D.8X @@U!!W$'I!Z"OS'\7]0$0$4MOH?_WB^I/]
M5]K_ *M\D$H<GOQ\M?YJ;ZTY4^[]O_;9F/NNP^_85>H%REH00$0$0$0$0$0$
M0$0$5##U@>3=5R:YHYE/Q.T;M]?ZHJJ_46'6,5\G:^U3C<NQGY3=P_+_ ,W>
M8G9E<3VF)*#7[U!CQUDKL[$HI9S3U%%J'5LK[5W%8VS1!&0=CN DO<.C;(YP
M!VU:&FM* >@3N:<K;OE;R0LK?+Q&'467F?D+ECA1\?;-8R")U=H++:.)SF$#
MLY7R-I7B)BY$<*UB B B BRKX;<N-C<+MWT&X]?&FQ99;739KALN6]$J,[PV
M:ZRY9X]8NM(=5%>)QAN3"E$VX<.<PT[V.(2MIS)M)ZHO])9AF5L?&:/%DC)H
MV2,[VGJZ"TT/"X T(J#$O.OD]IKG?H2XT7J+VM[B)+:Y:T.DM;EH(9,P&G$*
M$LECJWM(G/9Q-<6O;?9XM\KM,\OM95VSM-Y,Q:PUM1&LEQJ4XPQEF"WDA@W7
M<>RZG0\Z[73VE-K)ITC7%F-H-V,ZZT9+.ZNG-2XG5..;D<3(',H.-AIQQN/J
M7MZ#U'<[>TD;5Y]N:W*/6W)K5,FEM:VKH9@7&"=H)M[J(&@FMY" 'L-1Q-V2
M1D\$K&/JU9(COU&2 B B B B BKU>JGZO^.ZBJ,CX\\6<H@Y%N"Q9E4F<;-H
M9;,ZEU0TOM9GU%!/;;?@W.P7&5.,N.,+4U1KZ]RCG(-J/!G,GFG!BXI,%IN1
MLF5<"V29IJV'K:T[0Z7>"1LC^C%&[&NZ9W-,EK&\MN8_-BTDMM&1N;+:V,K2
MV6_(VLDF82'1V@-' . =="E!V#@Z2H&ZZZ^ZX^^XX\\\XMUYYU:G'777%&MQ
MQQQ9FM;BUF9F9F9F9]3%62234[25N58QD;!'& UC0  !0 #< .@#H"_,?Q?U
M 19A<->$>Z^;>QV<(U=4'"QZM>BNYYLFWC22P_ ZI]2C\^RE-)+W^ZF--+*!
M6,J]YF.),_M;"'GV<KTGH_+ZOOQ9XUM(&D=I*X'@C;X3TN/J6#:X]307"&>=
M?/70W(O3)SNJYN/(RM<+2RC<WRB[D'0QI])$TD=K.X<$8(]-(YD;[W7$_B?J
M3ASJ2HU-J:H\B*QY<_*,HGMLKR;.LF6RAJ;DF236D(\Z4]V=K#">D>'')++*
M4H21'<[3.F<7I3%MQF,;1HVO>?3R/Z7O/7U#<T;!L6@;F[S=UASIUA-J_5\W
M%*ZK((&$]A:P5);#"TG8T;W./CR/J]Y+BLF1D*BY 1 15"O6U]1V'N"^D\1M
M*7I3-:85=I>V[E-9(,X6=9O2R/\ -<2K7V5$B;BN%SVS<DN&:FIUNVA39>7"
M:>D5;YO:^9E9CI?$/KCX7^WO!V22-.Q@/2R,[2=SGTIL8"[<AW&.[1/HS'MY
MQ:YM^#5%]!3'P/'C6MK*/&N'@^EGN6&C!L=%;DAQXIWLCKOB"5L@0$0$6R7X
MJ;,J]R<:M$;/J)+<F-F>JL(MI/EJ;6<2X.AA1\@JGC90VS[W37T>3$?)!$@G
MF%$GP(A?_361CRVG[+(Q&K9K:-Q\#N$!P\UK@6GP@KS)<VM+76BN9^?TK>-+
M9;++74;:U\:/M7&&05J>&2(LD;7:6N%=J]^'=J/$!$!$!$!$!$!$!$!$!$!$
M!%\\N7%@19,Z=)CPH4*.]+F3);S<>+$BQVU/2),F0\I#3$=AI!J6M1DE*2,S
M,B(?ESFL:7O(# *DG8 !O)/0 OI##+<2M@@:Y\[W!K6M!+G.)H&M J2230 ;
M2=@6MEY.[+A[EY';WVO6*4=3L3;NPLPI.YLVEIHKW*K2?1MK0IME9.-5+S*5
M&I*5F9&:B[C,4!U%D&9;/WN3C^E3W4KV_0N>2W^#1>F_E9I>;1/+33^D;K_?
M,;AK.WEVU]MB@8R4@U(H9 XBA(IL&Q>&#I5GJ B B BR%XM\F-D\2-T8KNS5
M\UMN[H''(EK2S5O_ #)E^+SU-%=XGD+##C:Y%3:M,H/J1]\>2TS(:-+S+:T]
M[IS4.0TOEXLOCC[<S8YIKPO8?3,<!O:[YA <-H!4<\U^5^F.<.B+O0VJV$V%
MP Z.1H':V\[*]E<0D@@21DD=3V.?&^K'N!O[\3^6&I.8VI*C;.IK?SXK_EP,
MHQ>>XRC)L%R9#*'9N-Y)":6OR93/?W,/IZQYD<TO,J4A1&5W-,ZFQ>J\6W)X
MQU6G8]A]/&_I8\=?4=SAM&Q>>;F[RBUAR6UA-I#5\/#*VKX)V ]A=05(;-"X
MC:T[G-/CQOJQX#@LF1D*BY 1 1 1 1 14X_B!N0T#8O)# M$T%@B95Z%Q29)
MR3R%I-IK8.QSJ[2QKW#:4I$E53B=/3F1J/N8?E2&NU*B7W53YX9UE_GX,+ Z
ML=E$2^GU66A(\/"QK/,+G#9M6Z7Y.WEQ<:;Y9Y#7V1C++O4%VUL-1M-I9]HQ
MCQ7:WM+B2XV#8YL<;ZD%M(!A"*V%H"("("*Q'\/3R%@X;NK:G'>_L6XL7<&.
MUV6X6W*=;;:=S/7Y6'SG4P4J6E2IUYB=N])4717<W3%TZ'X*G?D7G66F7N<%
M.ZC;J,/CK]4BK5H\+F.)\R/T=;WRC?+F?-:'Q/,C'QE\N&N7V]R6@DBVN^#@
MD=L]+%<1M8-U#<]/1;R%HUIP0$0$0$0$0$0$0$6/O*+C=KWECI/,]([)B]U-
ME$+OJ[IAAEZVQ#)X:7'*#+J)3W0FK2EF*[NWN2B0PIV.[U9><2KH]1X"QU-B
M)</D![5(-C@/&8\>E>WPM/HBK3L)4B\JN9NH^4.N;+76F7TO;1])(B2([B!U
M!+;RTWQRMV5H2QX9(VCV-(UXF]-+YQQXVYGNE]C5_P W9?K^_D4EDA'<<6<P
M2&Y=3=UKBB2IZHR"GDL3HCAD1KC2$&9$9F145S.)O,%E)\1?MX;J!Y:>H]+7
M#YUS2'-/40O1YH'6^!YD:.Q^M]-2=IALC;B5E?3,.ULD3QT20R-?%(-H#V.
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M&6U*49)(S+FXK'39;)V^+M_IUQ,R,> N<!4^ 5J? %CVM-4V&B-(Y/6&4/\
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M=).]Q<YSB2YQ.TDD[23TDK:;C\?88FQAQF+@BML;;QMCBBB8V..-C11K&,:
MUK6@4#6@ #<%Q(^2Y: BEZX >D1NOF!)IL^SUJTT]Q\==:E.9A90O)RS.H"5
M$IR/K:DL&5)?CR4EV%<RV_FUKN-3*9JVUQQ*6B.5V7U2YE]>\5K@R:\9'CR#
MJB:>@_5'#@&\<9!:J;]X?OCZ&Y,Q3Z>T\8LUS% +1;L=6WM7]#KV5AV%N_R:
M,]LZE'F!KFR*YIH7C[J/C-KFIU9IC#J[#\3JB)UQN,DWK.\M%LM,R[_)+9[N
MG7E[/)E/FR7UJ5VI2V@D-(0A-LL)@\7IZP;C<3$V*U;U;W'I<]V]SCTD^8*
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M)_\ +R?5?.KXWS,)Q&G+228N(JTW-RU]O;QGP\+IYFGH, KM(5*(5$6\= 1
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M+.Y'F,?,FMDED[,24CJ1JBWE_#@UJ^GR%,Z_(0S+EOAOAS65E;/%8(I.V?\
M0Q>/0^!S@UA^B4#=[#7WYN^0N?RT+N')7=MY!;]![6]]H+FGUT43I9A_-K8&
MB\"\[2 B BUFFYZ)6+[AVQC*TO(5CNR\[HE(DK:<D(5491:UYID.,)0RMY)Q
M^BS01)-74R+H->V7A-OE;JW-:QW$C=N_Q7D;?07J)T1?C*Z+Q&4:6D7.+M9:
MMJ&GM((W[ =H&W97;3>O-1URR=9C\+^<.Z>#^QSS;5]DW88]<G$C9_K>Y==5
MBF=U,53ALLSFT$MVKNZ[SUJ@V<8DR8JU*2?FQW7X[V6:2UCE]'W_ )9CG<4#
MZ"6)WI)&CKZG#U+QM&[:TN:86YW<B-#\]M,_ 6JHC'DH.)UI>Q@>46LCJ5+2
M:"2)] )8'U9( ".&1D<C+M7#/U!N//-K&6YFMLC;I,_@Q$/Y5J3)Y$:%F^/N
M$DO>)$2*:TM91CZ%F7;95_FL)):$ODP\9LIM[I/7."U?;\>/DX+YHJ^!Y D;
MUD#U;?GVU&[BX3L6C#G9W=.8_(O*&#4]L9].R/(@R$ <ZUF'0USM\$Q&^&;A
M<:$QF1@#SG(,Q4#H"("("("("("("*'3U.O52PCAYC5KJ_5EE3YER9NX*H\6
MI:<185.J8LZ.9M9/FA-&IE5V3+A.UU.I1/.FI$B2E$4T)DQ3S$YDV>E;=V.Q
MKF2ZA>*!N]L((]/)\]TL9O.QSJ-IQ71[K/=,SO.?*0ZJU9%-9<KH)*ND(+)+
M]S3M@MJ[>RJ.&:Y X6T='$3+Q&*D7?W]WE5[<Y/DMK/O<BR*TGW=[=VLIV;9
MV]Q:RG9UE9V$Q]2WY4V=,?6XZXLS4M:C,SZF*@3SS7,S[BX<Y\\CBYSG&I<X
MFI))WDG:2MZF/Q]CB;"#%XR&.WQMM$R***-H:R..-H:QC&B@:UK0&M V  !<
M2/DN6@(IU_2(]+NSY*953\AMYX\]$X[XI8>^8S1VC*FE;ER>JEI)N$W%=01O
MZ\IY;*OG*2?VJ>^W[BUYA>^*CS-RNY<R:@N69W,QD8*)U6-/\N]IW4Z8FGTY
MW.(X!7Q^&@W?&[U=KRQQ,W+C05RU_,B[CX9Y6&OP;!(W:XN&Z\D:1V+/31,=
MV[^$]B)+G;;:&D(::0AMMM"6VVVTDA#:$$24(0A)$E*$I+H1%X$0MF  *#<M
M)+G.>XO>27$U).TDGI*_V/ZOX@(@(@(@(@(@(H&O4^]'N@Y)G>;UXWP:G$=]
MFVN?DV'$<*FQ+;KK9/.R)9NFAB)C^Q)JE%_GSBT0K%:2*7Y;JUS"A;F+RK@U
M!QYG !L6;WOCV-9/UGH#93ZX^*[U5"2]; .ZOWSLARQ$&@>9DDUYR^J&07/C
M27&/!H VFUTUFW;[4 980?:>)K1":>67X?E>O\GN\+SC';K$LMQN>]5W^-Y#
M72JFZJ+!CIYL2?7S6V9,=TB42B)22)25$HNJ3(SJM=6MS8W#[2\C?%=1NHYC
M@6N:1T$':%N>PV:Q&HL7!G,#<P7F'NHQ)%-"]LD<C#N<Q[26D=&P[""#M!77
M!QUV2 B BG=],;UAL@XR-4FC.1;]OF6@D.E#QS+&DR[?,=1M/*;2U'9C][TG
M)-?Q%$9G7MI.; 0HSA^:A"(2YHY=\U)]/!F&SQ?+A*T8_:Z2#P4WOB'K1XS?
M45 ##0/O3=S''<TG3Z]Y:MALN81'%-;GACML@16I)V-ANW;/;B1%*0!-P.<Z
M<7"\%SS#-G8E19YKW)Z3,L-R:"W8T.28]81[.ILXCAFGOCRHRUH\QEU"FW6U
M=KC+J%-N)2M*DE:BRO;3(VK+VQD9+:2-JU[2"TCP$>@1O!V':M,>?T_F]+9B
MXT_J.UGLLW:R%DL,S"R1CAT%IZ"*%I%6N:0YI+2">VCE+IT!$!$!$!$!$!$!
M$!%$YZCGJGZNX5X_:8/B$FIV'R1LJ\TT>#1Y!2ZG!E3F%*AY)LJ1$>0J!&9;
M4E]BI2XBQL$J;/HQ&=]Z3&6O>9.-TC ZSM2V?/N;XL8-6QU&Q\I&X=(97B=L
M]*T\2MYW:>Z=JOGAD8L]F6S8WEE%)[;=$<,EUPGQH;(.'CN)JU]P0882'?3)
M6]D:0VRME9WN'.\FV9LS)K/,,YS"S>M\AR&W>)V7.ENDE"$(0A+<>'!AQVT,
M1HS"&XT6,VAEE"&D(05/\AD+W*WLF0R$CI;R5W$YSMY/[  &P 4      "WK
M:8TQ@-&8"UTOI>UBLL#91".&&,4:UHVG::ESG$ESWN)?(\N>]SG.)/1APEWR
M BSNX.^GSO#G-F?S;@L!6,ZUI9[$;.]N7D)Y>,8RA24/NU]:UYL5>4Y6N*M*
MFJR*X2D^8VN2Y&863PS31VALQK*[[.S;V>/8ZDD[AXC/ -W&^FY@/2"XM!JH
M!Y\=XO0?(7">4Y^076IYXRZUQ\3AV\YV@/>:.["W#@0Z=XH:.;$V61O KQO%
M/B3IGASK"#K#3N/E#C]&).4999(B2,QSNZ:2Z1W>6W$:+%.?)0;[B8[*$-Q8
M32O*CM-HZD=Q=-:8Q.E,<,=BF4;O>\T,DCO7/< *G::#8&C8T +0]S;YP:VY
MTZJDU5K2XXY-H@MV%PMK6(T]JMXW.=P-- 7N),DKAQ2.<[:LFAD*BY 1 1 1
M 1 1 18U\Q-V0^.G%_>.Y9,Q$&5A>O;Z1CKJUH;\[,[6/\Q8/!2M:DD2K#,+
M2"P1EU47F=22HRZ'C^JLNS Z<O,LX\+H8'%O\XX<,8\]Y://4G<E]#3<R>:N
M!T5$PR17V1B$PH32VC/:W3MGK+>.5W5LVD;UK?A05>F) 1?5!FRJV;#L8+RX
MTV!*CS8<AOIWQY45U#\=Y'<2D][3S9*+J1EU(?MCW1O$C#1[2"#U$;0OE/!%
M=0/MKAH=!(PM<#N+7"A!\T&BV6>B-IU6\-+:JV_2K957[)P'%LQ0VPX3J8<B
M\IXDV?6.*+IVR:FP==BO),B4AUE23(C(R&P3"Y*+,8BVRL-.SN(&2;.@N:"1
MYK34'PA>8+7^D[O0FN,MHR^#O*<9D)[8DBG$(I'-8\?.R,#7M.XM<"-A7K [
M-8B@(@(@(@(@(@(@(@(@(@(@(@(@(@(JT?K'>E4>6MY/R\XVXZXYEK12;W=V
MMJ=E)EDL-B.IZPV1B=>TDE?A+&0T;EQ":(_G)'=+:3[VE\IE?.:W+7RH2:IT
M_'_2A5UQ$WU8 VRL'KQO>T>G],/&XN/:!W+>]I\#NM>3G,VY PYX8L9>R'Z0
MXFC+*X>?Y!Q-+>5WTDTA<>Q,9AJC"M"VX("("*6WT/\ ^\7U)_JOM?\ 5OD@
ME#D]^/EK_-3?6G*GW?M_[;,Q]UV'W["KU N4M"" B B B B B BX3(\EQS#Z
M2QR7+<@I,6QRGC.3+;(,CM8%)25<-HNYV58VMF_%@0HS:2ZJ6ZXE)%\ICXW%
MQ;VL+KBZ>R.W8*N<]P:T#K+B0 /"2N=C<7DLS?18O#V\]WDYG!L<,,;Y99''
M<UD; Y[G'H#0256"]3'UKZ3(\<R;0/#:VFR8UY%F4.<[X;;D5J#JI+2HUG2:
MM9?0S8^;/9<6P]>NH84TWW^X(4I;4UNNW,+F[#/;R832CB6O!;)<[1L.PMAK
MMV[C(:4%> ;0\;4>Z]W&[[&Y.UYA\ZH6-EMWMEM<42'^V-/$R6^()91A <VU
M:7!QIY00&O@=6"%=%M10$0$0$0$0$7JVF]X[;X^9K!V'IG/LAU]ET#HA-G0S
M#:;G1>]*UUMU6OI?JKZH>6DC<B367XSAD1J09D1EV>)S.4P=XV_Q,\D%TWI:
M=XZG#<YO6UP(/4L2UKH/1_,7!R:;UMC[;(X>3;P2MJ6NI0/B>*212#HDB<QX
MVT=M*L4\</B(Y,:+!HN5>G'+)YHFV7MA::<CQY,A*>UI+]EK[)[)B&<E1?;'
MWHEPRV:NOE1$%T24\8#GLYK6PZEM.(C^5@H"?-B>0*])+9 .I@W+6WS,^3=B
MEEDO^4N:$3#4BSR0):.FC+N!A=P]#&R6SG4IQS$U*E\UMZM'I];.C1W*WD;B
MF*S7NB7ZO9,*\UY)@NFGN\F1.RJLK:%[HGIU<CS'V.I]._N(R*4L?S.T/D6@
MQW\43ST2AT1'FEX#?/#B/"J:ZF[H'>*TM*YMSIJ[NX&[I+)T5XUPZPR![Y1Y
MCXVNZ>&FU9*PN7'%*RC-S:[DYQZGPWN_R9<+=&MY49WRW%M.>6^QDKC3GENM
MJ2?0SZ*(R/Q(9"S4^FI&A\>1L7,/2)XB/1#U&$_)[FY;2F"YTMJ..9M*M=C;
MUKA45%08014$$> U70<I]0;@YAS3KMURQT(X;)NI>C4&R\8RV>TXPLFG6G*W
M$["[L$/(6?3L-HE^!^'@?3@W.N='6@K-D[+9T-E8\^@PN/S%D.)[NG/C-/#+
M'2&H1Q4HZ6RGMV$$5!#[AD3"*=/%3=MVA8';D]>OA)KUB4QKA6P=YW2"4B*C
M%L7F8EC:I*2/N1/OL_;Q^R8C$HC3YT2LGDH^AI)2#[AA>6YU:0L6D6';WDW1
MP,+&5\+I>$@>%K'>#9M5@-%?)]\]-1R,DU,,=@+$[7=O.VXFX>MD5H9F%W3P
MR3Q4Z2#L4!_+KUF>5_*&!98=C\Z)H76%DV]&FXKKB?._".]@/=Z5P\IV"^F+
M=SXSC#BFGH]>U50I32C2^PZ0A/5'-C4VHV.M('"RQSMA9$3QN'4^78XCH(:&
M-(],TK8-R<[D_*+E5<19K(QOU!JJ(AS9[UC.QB>*4=!:#BB8X$!S7S.GEC<*
MQR,41PB]7#0$7WU=5:7EE!IJ2MGW%O:2F(-955<.1865C-DN):CPX,&(V]*E
MRI#JB2AMM*EK49$1&8^D<<DTC8H6N?*XT#0"22=P &TD]07'N[NUL+:2]OI8
MX;.)A<^21P8QC6BI<]SB&M:!M))  WJ?/A%Z$VW=LO4^?<K7[/2NN5FQ.:U[
M&)DMN91&,N\H]BQ(1(A:YB.]4]_OK<BT+M6VJ''-2'RFS1_)G*9,LOM2EUI8
M;#V0^GO'40:B(?1 OWC@;L*U[\]>_P!:.T@R;3W*1L6<U**M-XZOP? [=5A!
M#KQPVT[,L@VAPFD ,9MCZATWK#0F TFL=08938)@^/M=E?1TK"TH6\M*$R;*
MRFR''[&ZNIYMDJ3.F//RY*R[G7%J\19K%XG'82R9CL5"R&S8-C6CT22=KG'I
M<XEQZ25J'UEK757,'4$^J=97T^0SUP:OEE.X;:,8T ,BC96C(HVMC8-C&@;%
MZ8.P6+H"+S_9>UM:Z:Q6=F^ULZQ;7N)UR35*O<LN85-!\PDFI$6,N8ZVN=/?
M,NUF,PER0\LR2VA2C(CX.0R>/Q-LZ\R<T<%JW>Y[@T>8*[R>@"I/0%D6E]):
MGUKEH\%I&PN\CEY3XL5O&Z1U/7.X00Q@WN>XAC14N< "55N]1WUO'METU]I'
MAS*NZ##[5A^JR[=LN-*HLDR.MD-*9EU.OZV2EBVQBIF,N&AZRE(CVCA&I#+4
M8B\UVN.ON<!R$3\/I0O9:N!#[@@M>\'>V('QF-/2\T>=P#=YVM]VCN*,TO>V
M^NN=+(+C-0N$EOC&N;+#"\&K9+M[:QSR-(JV&,O@&PO?*3P,K=B 5LS0$0$0
M$5@CT</5"QKCDRYQFY"W:ZG4%U<OV>N,YE)<>@ZXR*\EI7;TN0+):C@8/>S7
M53"DH0:*Z>X\Z\7D2''8\X\J>8UO@!\7LZ_AQ3WDQ2'=$YQ\9KNJ-Q\:OJ7$
MD['$MUV=]/NJY/F6\<T>7, FUE! &7EJV@?>PQ-I'+#L\>ZB:!'P$UFB#&L\
M>-K)+?E3;U-_5U]W16===4MM$8L*JWJ9L:RJ[.!*;2]%FU\^&Z]$F1)+*R4V
MXVM2%I,C(S(6EBEBGC;-"YKX7 $.:000=Q!&P@]!"TUWEG=XZZDL<A%)!?0O
M+)(Y&N8]CVFCFO8X!S7-.PM< 0=A"Y$?1<9 1 1 1 1 1 1 1 1 1<+D61X]
MB%)9Y-EE]2XOC=+%7.N<@R*T@TE)4PFNA.3+.VLGXT"!%;[B[G'7$(+KXF/C
M/<06L+KBZ>R.W8*N<XAK6CK+B0 /"2N;C<9DLS?Q8O$6\]UDYWAL<,,;I99'
M'<UD; Y[W'H#02JM/JK^L7C&P\2R;C-Q-N7[7'<C9DT.TMRQVY,&%;TJS)JR
MP[7GFDQ+EUENDEQ[&U<0AF3%-;,0G67O>17#F5S5M[ZUDT]IAY=!("V:<5 <
MWICBW$AVYSSL(J&U!XEM?[I/<NRNG,Q:\T>;T#8<E;.;+8XTEKG1RC:RYO*5
M:U\>Q\, )<R3A?,6/9V2K-"O2VB("("("("("+(WC#RKW3Q#V3$V;I;*'*6S
M(F(M_0S4NS<4S2E:?)]=!EM*EYA%E7.*Z]BTK:E15J-R.\R[T67?Z=U+E]+9
M 9'$2<$FYS3M9(VM>%[>D>@1O:0=JC7FIRDT/SDTP_2VN+03VNUT,K:-N+:4
MB@EMY:$L>.D$.C>!PR,>RK5<7X6>L3QEY3Q*G%\TN(&B-S2$QHK^&9O:QXV,
M9%9.%Y:CP;-Y28E58^\OFE+4":<.R4XX3;34@DFZ=J])<U=/:D:VVNWMLLL:
M#LY' ,<?]'(:-->AKN%]30!V]:7.=_<OYI<IYILK@X9,_HEI<X7-K&73PL&W
M^E6K>*1G"*ETL7:0@#B>^.H8)<1*"IX@(@(N)O+ZCQFKEWF27-3CU+ ;\V?<
M7EC#J:N$UU)/F2[">]'B1F^XR+JM:2ZF/E-/#;QF:X>V.%N]SB&@>:30!<NP
MQ]_E+MEAC()KF^D-&1Q,=)(X]36,!<X^  J$OG#ZV_'_ $GB]_B/&[(:C>&Z
M9,>17UEM2)78ZLPV6X@VRNK?)D&U RYV'WDXQ"J7)+#ZT&E^3'(NBXAUCS?P
M>(MGVN D;>9<@@.;MAC/KG/W/IO#6$@[G.;TWGY$=Q?F)KG*V^8YFVTV!T0U
MP>^.6C+^Y:#7LHX-K[<.I1\MP&.8#6.*0[J:6591D.;Y-D&99;;S;_*<JN;+
M(<BO+%WSI]O=7$QZ?9V,MWHDER)DQ];BNA$757@1%X"I]S<SWEP^[NG%]S*\
MN<X[W.<:DGPDFJW78G%8[!8NVPF'A9;XFT@9##$P49'%&T,8QHZFM  \Q<"/
M@NP0$0$0$79\*S3*M<Y?C6>X/>3L:S##[NNR+&K^M6EN;4W-3*;F0)K!N(<:
M6;+[1&:'$K;<3U2M*DF:3Y-G=W-A=1WMF]T=U$\.8X;VN::@CS^O8=QV+J\Y
MA,3J7#76G\]!'=8:]@?#/$\5;)'(TM>TTH14'>"' T+2" 5<[X.>M5Q]Y T%
M+B6_;V@T-NIF.S$L7,AF%5:NR^6@D-*M,:RRQ>]QQYV:YT6JMM7F5M+63;#\
MLB-96ST=S<P><@9:YM[+++@4/$:0O/6QYV-KZQY!&YKG;UI)Y\=QWF+R[R$^
M8Y>V]QJ#0[G%S!"WM+ZW:=O!-;L'',&C8)K=K@X#BDCAJ 9JH<R'8Q(T^OEQ
MIT&8RW)B38;[4J)*CO();,B-(84ME]EU"B-*TF:5$?4C$N,>R1H>PAS"*@@U
M!'6"J/30S6TSK>X8Z.=CBUS7 M<TC80X&A!!V$$5"^D?I?) 1 1 1 1 1 14
MM/7@W!QUVQR4PIK3MA!R?8&"XA88GN',L>?BRL7G2H]HB5BN-,3XBE,W&18J
MA^P3826S<;;1)CQ/,4Y&<:8J3SHRN!R>H(1BG-DOH8BR>1I!82#5C 1Z9[*N
MXB*@ M;6K2&[ONX#HSF3I'EC?/UI'):Z=O[QEQCK:8.;.QIC+;B8L=MCAG(A
M,+#0N+))N$-E:^2#40VKY("("("("+W'C]R/W-Q=V!!V7I+-[/#,EC$B/.1&
M4F32Y%5DZEUZCRBCE$Y6WU/(4DC-E]M1MK(G6E-O(0XGN<'G\MIR^&0P\SHK
M@;#3:UP]:]IV.:>HC8=HH0"L$YB<L]$\UM.R:7UU817N,=4M)\66&2E!+!*V
MCXI!ZYA'$*M>',+FFV'PV]=?0.Y8U3A_)-F+H#9;ODPUY(\Y(E:?R&4I*$^\
MLW[IO3L%6\YWJ6S;]8,=!)_ZQ<4KL39G2G.;"99K;74 %CD#LX]I@<>OBVF/
MS'^*!_*'<M1'.KN"\PM%2S9GEBY^HM,"KNQ #<C"W;XIA%&75!0!UO[:\U_H
MS0*F<ZFNJ;(ZJ!>X];5E]1VL9N95W--/BVE590W2ZM2H%C!=?B3(SI>*5MK4
ME7V#$R1317$39H'-?"X5#FD%I'6"*@CPA4+O;&]QEW)89&&6WOX7%KXY&.CD
M8X;VO8X!S7#I! (7)CZ+BH"("("+CK:WJ:"LG75[9UU+3UD9V996UM-C5U97
MPV$][TJ=/F.LQ8D9E)=5+<6E*2^4Q\Y98H(W33.:R)HJ7.(  ZR3L \)7)L[
M.[R%U'8V$4D][*X-9'&USWO<=S6L:"YSCT  DJN1ZGOK-8)2X?E6@.(>5,Y?
MFN1PY6/YAN?'I!NXOA]/-9<8M(.O[MA9-Y#E4V,YY2;2(I<&O0LUL/.2B(X\
M"\Q>;-E#:RX/2THEO) 6R3M/B1M.PB)P],\C9QM\5H-6DN]+LL[J_<FS]]F;
M3F'SCM'6>#MGMFML;,*3W,C2"Q]W$=L,#7#B,$@$LQ $C&Q5$M3(5C6WM 1
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M5Q _LN<?_P!4^)"^^COQ1Q7]FVWUEB\TO/?].&L_[UY?_J%PLHQD:BE 1 1
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M>9)"72.)))-22=I))VDD[RMA,$$%K RUM6,CMHV!K&- :UK6BC6M:*!K6@
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MP(C;46%!A16DMM--I2AM"22DB(A9Z&&*WB;! UK(&-#6M: &M:!0  ;  -@
MW+3[?7U[D[V7(Y&62?(3R.DEED<7R22/)<][WN)<Y[G$N<YQ))))-5R8^BXJ
M B B B B B B B BP"YO^G+H'G)CO7-ZT\/VE5P3AXGN+&(48LJJFD*4['J[
MZ.M4>-F.,(?49^XS%I6R3CAQ'XCCJW#PC6&@L)K&#^F-[+)-;1D[ .-O4'#8
M)&5]2[=MX7-))5AN1/>5YA\ALE_P*7RW2<LG%<8Z=SNPD)V&2(BIMIR-G:Q@
MAU&]M',UC6BFAS']._DCPINWBV5BR[W7<F:<;'MNXBS+LL$MDO.K1!C6,PV$
MOXK?R4(__E]BEEU:DK]W5(:3YIU/U7H3/Z1F/PA'QV!-&SLJ8W=0)IXCCZUU
M#OX>(;5NOY+=Y#EESQL6G3%V+?4C6<4V/N"UEU'0#B<QM:3Q-)^G0ES0".T$
M;CP#!888I[0$0$68?$KG7R-X79(JWTWF2D8Y836IF3:UR1,BYUYE2D$TVMRS
MH?>8RX-DXPREOYPKWH=@EM)()_R^J#RO3&L\_I*X[7$R_P!'<:OB?5T3_-;4
M4/1Q-+74V5IL4,<X.07+7G=C!9ZUL@<G&PM@O8:1WD%:D!DO"X.8"2>RF;)"
M22[@XMJM9<3?6^XI;[8K,>VS/+CCLA\F([\/.)[;VN+*8HB2X[3[&)F+6UD8
MU%W&F[;JR;[B0AQXR-1V5TSS@TSFVM@R;O(,@:"DA]J)^=EV #^<#*;@3O6I
M+F]W$^;G+Z27(Z0C^,NF6U(=:L(O&-Z!)9U<][NBMLZ>M*EK-RF1J[6KO*Z'
M<4EE N*FQCMRZ^TJYD>PKI\5TNYJ3#FQ''HTJ.XGQ2M"E),OD,2O'+'-&)87
M-?$X5!!!!'6"-A"I7=VEW87+[*^BDAO(G%KXY&ECV.&]KFN <TCI! (7WC]K
MCH"("("("+P7>_*#C_QFQ]S(]Y;5Q'7T3W5<R%6VMBE_)[QIM2FU)QO$:],S
M)\C=\Q!I-,*(^:>AFKH1&9=+FM1X/3T'E&9N8H&TJ X^.[Z!@J]_[EI4@Z Y
M5<Q.:.1&,T'B+S(S<8:Y\;*01$[?;KA_#!"*&M99&UV4J2 JS?-OU[,VSV+=
M:ZX?4UCK3&I12:^9N/(T,*V':Q%]&G%X=1H]XK\';?;)9)FON3++RW$K:3 ?
M;)0KUJ_G7=WK7V&E6.M[<U!G?3M2/]&W:(_HB7/H:C@<%M#Y%_)]X+3\L&I>
M<T\>4RC.%[<=#7R.-PV@7,NQ]T0:5C:(X:@M>;B-U%77M;6TO;.PNKNRGW%S
M;39-E:VUK,D6%G9V,UY<B9/L)\MQZ5-FRY#BG'77%J6XM1J49F9F((DEDFD=
M-,YSY7$ESB222=I))VDD[R=ZV26EI:V%K'8V,4<-E"QK(XXVAC&,: &L8QH#
M6M:  UK0    *+X!\UR%R%346M_:5])15EA=75M+8KZNHJ84FQM+*?*<2S%A
M5\"&T]+F2Y+RR0VVVA2UJ,B(C,?2**6>1L,+7/E<0 UH)))W  ;23T +CWEY
M:8^UDOK^6."RA87R22.:QC&-%7.>]Q#6M:-I<2 !M)5B?@?Z$6:9TY2;-YE'
M.P##%&S/@Z4KI2HVP,CCGY;S"<TM83O3!:R4VHB<AL+5=&1J0X=>ZDC.=]%\
MF+N\+,CJSB@M-XMP:2O'^D</I8/2T'M-X/ 0M;?/_O\ F$P#9]+<E.SR.;%6
M.R;V\5I"=H/DT;A_2GM.Z1P%M6CF^4,.RU?@6 83JW$*' -=8M287A>,045U
M#C6/0&*VJK8J%*<4EF.PE)+>D/N*=>>6:GGWEK<<4MQ:E'96RL;/&VK+&PC9
M#:1MHUC10 >9X=Y.\FI))*U*:@U#G-5YFXU#J6[GOLW=2%\LTSR^1[MVTGH
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M?RLK8FB*6('C>UD1B:]_&#;!I[FHR&L@W=!:UMY36<=$NMMZ>=%LZRPBN?\
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ME=&8\8K2.-L<9CA3VNV@CA:2-@+A&UO$[?5SJN))))))7GPX*R) 1 1 1 1
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MV\SZ*KRUF2O=K6.A?RFGP+I'69YLZTS#71"X;:V[M[8&\!]T)=(/.>/,5JM
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MOC,PX,&'&;2U'BPXD=#<>-&8:024(0E*4I(B(B(3$QC(F".,!L;10 "@ &X
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M1,NU_'?0NTM9:8,*.Y)PW(<N8;0[+<0GS%&2$DX1J-)$KMS+'<Y=&Y"9EO\
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MKG+-79 QX$.JRPM08;-FVHXHPXNG<T^E?</F>VIX'-!HLX1F*@A 1 1 1 1
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M>NO?=6_8T_Q#^?GU'3_O2;^MI_#_ '!7^>-]_2!C?XA!^9#1GKKWW5OV-/\
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M_P"])OZVG\/]P5_GC??T@8W^(0?F0T9ZZ]]U;]C3_$/Y^?4=/^])OZVG\/\
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M(=MLQPM[4C: #;6XBA=0$@%['.I6KB22<NAE"AU 1 1 1 1 1 1 1 1 1 1
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M20.-/ V+M-O@<6^<JY:N[_G(#3K7,PL^1S=T-@%I:OC9Q=3I+PVPX?GHVR>
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MI-_6T_A_N"O\\;[^D#&_Q"#\R&C/77ONK?L:?XA_/SZCI_WI-_6T_A_N"O\
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MUL)WS1>30R1.XWLX#Q%\TH(IN  V]*S\&;*O2 B B B B B B B B B B B
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M0$0$0$0$0$0$0$0$0$0$0$0$0$4:^Q_^U&>?^_LH_P!(3A@%_P#[Q/\ 1O\
MV2K-Z9_Y7C_N>#^(Q8D<;_\ H66?_A51_P#>IXQ;3WI)?-;_ )5,/,[Z?9_0
M2?LL4O.AO]W\?_WK9_\ WQ E/#?[B/HBJ<Z__&%W\RS]@KV8=JL)0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$
M0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$4!?J9?\ 3<J_
M_!+[_P"_4XA/F%],D\QW^:MA/==^D6GT<7[$BJ;[M_WBV_\ ^#57^C(HK-F?
M^8/\QO[ 6WC0GXM0_1R?QW+J^O?^W.)_^_ZS_P#6FQQK#_?8OHQ^RNUU)_R"
M\^YW_P 4JR'P-_Z57?\ O7)O]"LB?=%_3&_1/_BK69W@/I,O\S!]=*M0BR*U
M.("("("("("("("("("("("("("("("("("("("("("("("("("("("("("(
M"("("("("("("("("("+RW5__P#<3]*66_\ ]/'78[^7^Z7_ .195JK_ .F_
MV5;_ .>O4AV*Q5 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
M 1 1 1 1><;=_P!W.3__ (+%_P!)0AP,G_N$GF#]D+)='_C+:_1N_B.5/;FO
M_P!-M_\ W!F?_P!]FBK&K?3/^@D_RK<WR.^D0_=%M^PU0="&U?!99\8OY5__
M .],?_\ VS1E.G/Y3Z)O^51!S4W6_P#-2_YJN3>GM_S5U_\ @M[_ /KN*BUF
MA?2O\QW[+%I5[QGTR#Z*+^+<*3P2*JL("("("("("("("("("("("("("("(
M"("("("("("("("("("("("("("("("("("("("("("("("+QGD#_NHO_P#W
KKA7].L:'4YS_ ):_Z*/ZXQ9MR[_&VW_F;G[UG7LP[982@(@(@(@(@(O_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
